<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Autacoids Part 2 - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        DocTutorial / qBank / Pharmacology
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">19</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x2bb813=_0x1e9d;(function(_0xc79296,_0x5a10c8){const _0x559225=_0x1e9d,_0x2bf6f0=_0xc79296();while(!![]){try{const _0x311812=-parseInt(_0x559225(0x243))/0x1+-parseInt(_0x559225(0x468))/0x2*(parseInt(_0x559225(0x2d4))/0x3)+-parseInt(_0x559225(0x1d7))/0x4*(parseInt(_0x559225(0x1ef))/0x5)+parseInt(_0x559225(0x37e))/0x6*(-parseInt(_0x559225(0x23a))/0x7)+-parseInt(_0x559225(0x39d))/0x8+-parseInt(_0x559225(0x3aa))/0x9*(parseInt(_0x559225(0x2e6))/0xa)+parseInt(_0x559225(0x46c))/0xb;if(_0x311812===_0x5a10c8)break;else _0x2bf6f0['push'](_0x2bf6f0['shift']());}catch(_0x4f2b97){_0x2bf6f0['push'](_0x2bf6f0['shift']());}}}(_0x5dea,0x5a196));const _0x5495a6=(function(){const _0x3ce4d3=_0x1e9d,_0x4ec831={'GvViP':function(_0x2a8c8a,_0x47721c){return _0x2a8c8a!==_0x47721c;},'clsYj':'zaXIt','CMCnK':_0x3ce4d3(0x30a)};let _0x4266cd=!![];return function(_0x567713,_0x44f602){const _0x1ad112=_0x3ce4d3,_0x1f243c={'mMcwD':_0x1ad112(0x1e1),'nOKjU':function(_0x2ff424,_0x8d104f){const _0xadf8ff=_0x1ad112;return _0x4ec831[_0xadf8ff(0x3db)](_0x2ff424,_0x8d104f);},'mcuKZ':_0x4ec831[_0x1ad112(0x224)],'gbLyC':_0x4ec831[_0x1ad112(0x325)]},_0x2b64b1=_0x4266cd?function(){const _0x1bb617=_0x1ad112,_0x2d0e2b={'sVpzn':_0x1f243c[_0x1bb617(0x3d5)],'KMJGr':_0x1bb617(0x314)};if(_0x44f602){if(_0x1f243c[_0x1bb617(0x27f)](_0x1f243c['mcuKZ'],_0x1f243c[_0x1bb617(0x24d)])){const _0x52ce3a=_0x44f602['apply'](_0x567713,arguments);return _0x44f602=null,_0x52ce3a;}else{if(_0x11a980)return;const _0x40ec76=_0x505c1a[_0x1bb617(0x33a)](_0x4ff988[_0x1bb617(0x416)](_0x2d0e2b['sVpzn']))||{};_0x40ec76[_0x218042]={'questionStates':_0x30b19f,'stats':_0x488298,'currentQuestionIndex':_0x5a4f01,'currentMode':_0x2f4ad1,'status':_0x2d0e2b[_0x1bb617(0x453)],'lastSeen':new _0x72da06()[_0x1bb617(0x3a3)]()},_0x5e5312[_0x1bb617(0x299)](_0x2d0e2b[_0x1bb617(0x1c1)],_0x4336fa[_0x1bb617(0x3ba)](_0x40ec76));}}}:function(){};return _0x4266cd=![],_0x2b64b1;};}()),_0x5f4b3e=_0x5495a6(this,function(){const _0x1761f1=_0x1e9d,_0x25e192={'izmFe':'(((.+)+)+)+$'};return _0x5f4b3e[_0x1761f1(0x3bd)]()[_0x1761f1(0x1c5)](_0x1761f1(0x3dd))['toString']()['constructor'](_0x5f4b3e)['search'](_0x25e192[_0x1761f1(0x44d)]);});_0x5f4b3e();const _0x15ad2e=(function(){const _0x287a46=_0x1e9d,_0x5a1985={'ukUQQ':function(_0xdbe6d7,_0x124ce0){return _0xdbe6d7!==_0x124ce0;},'DxTmW':_0x287a46(0x30e),'XCzok':function(_0xc6acb2,_0x5ba7ad){return _0xc6acb2===_0x5ba7ad;},'drulE':_0x287a46(0x34a),'Kkart':_0x287a46(0x451),'GoRqG':_0x287a46(0x1e7),'tzNCH':function(_0x45429a){return _0x45429a();},'fqgmX':function(_0xe3904a,_0xab0c95){return _0xe3904a===_0xab0c95;},'ZPCyY':_0x287a46(0x230)};let _0x3ce583=!![];return function(_0x535ca6,_0x41af2c){const _0x234906=_0x287a46,_0x302957={'VSgOS':_0x5a1985[_0x234906(0x2c1)],'HgxJS':_0x5a1985[_0x234906(0x205)],'jcviD':function(_0x2f574e){const _0xd67599=_0x234906;return _0x5a1985[_0xd67599(0x384)](_0x2f574e);}};if(_0x5a1985[_0x234906(0x34c)](_0x5a1985[_0x234906(0x23c)],_0x5a1985['ZPCyY'])){const _0x14dde4=_0x3ce583?function(){const _0x556e16=_0x234906;if(_0x5a1985[_0x556e16(0x1e5)](_0x5a1985['DxTmW'],_0x5a1985[_0x556e16(0x1c4)]))_0x35af4a=_0x186e6a,_0x15cf85[_0x556e16(0x2bd)](_0x302957[_0x556e16(0x2a7)])[_0x556e16(0x27b)][_0x556e16(0x244)]=_0x302957['HgxJS'],_0x302957[_0x556e16(0x2e8)](_0x3facd0);else{if(_0x41af2c){if(_0x5a1985[_0x556e16(0x3e3)](_0x556e16(0x27e),_0x556e16(0x376))){const _0x12a4b5=new _0x5e0f8e();_0x12a4b5[_0x556e16(0x26e)](_0x4c08f2),_0x12a4b5['attachMedia'](_0x123130);}else{const _0x1a3e3d=_0x41af2c[_0x556e16(0x265)](_0x535ca6,arguments);return _0x41af2c=null,_0x1a3e3d;}}}}:function(){};return _0x3ce583=![],_0x14dde4;}else{const _0x447701=_0x23de5f[_0xbcf464];_0x5a1985[_0x234906(0x1e5)](_0x447701[_0x234906(0x2c0)],null)&&(_0x5a1985[_0x234906(0x3e3)](_0x19f231[_0x234906(0x2e7)][_0x447701[_0x234906(0x2c0)]]['id'],_0xa0b2e5[_0x234906(0x2d3)])?(_0x53fb6b++,_0x447701['status']=_0x5a1985[_0x234906(0x1e0)]):(_0x1bf764++,_0x447701[_0x234906(0x458)]='incorrect'));}};}()),_0x4d8348=_0x15ad2e(this,function(){const _0x3d0c55=_0x1e9d,_0x2d9fd0={'oUDib':function(_0x424376,_0x439041){return _0x424376===_0x439041;},'iMrSL':_0x3d0c55(0x2f8),'ewvtC':'TOiuD','JxKiB':function(_0x14ac16,_0xf29d8){return _0x14ac16(_0xf29d8);},'Grall':function(_0x433880,_0x3177c3){return _0x433880+_0x3177c3;},'BfnCW':function(_0x30ec55,_0x1afb01){return _0x30ec55+_0x1afb01;},'ixSqM':_0x3d0c55(0x3b5),'rezPQ':_0x3d0c55(0x45f),'FXrsa':function(_0x8aaaae){return _0x8aaaae();},'leFGd':_0x3d0c55(0x35a),'TRZmm':'warn','upqxO':_0x3d0c55(0x1cc),'MQVci':_0x3d0c55(0x3c5),'pvTbP':_0x3d0c55(0x45c),'actZp':function(_0x297d1f,_0x26d703){return _0x297d1f!==_0x26d703;},'xOWGP':'eMFOQ','xRZRV':_0x3d0c55(0x1da)},_0x3937ce=function(){const _0x5e5442=_0x3d0c55,_0x1bb84e={'TGkAf':_0x5e5442(0x3ad)};if(_0x2d9fd0[_0x5e5442(0x24a)](_0x2d9fd0[_0x5e5442(0x3ff)],_0x2d9fd0['iMrSL'])){let _0xbcdb29;try{if(_0x2d9fd0[_0x5e5442(0x24a)](_0x2d9fd0[_0x5e5442(0x3fe)],_0x2d9fd0[_0x5e5442(0x3fe)]))_0xbcdb29=_0x2d9fd0[_0x5e5442(0x2a9)](Function,_0x2d9fd0[_0x5e5442(0x27c)](_0x2d9fd0[_0x5e5442(0x46b)](_0x2d9fd0[_0x5e5442(0x250)],_0x2d9fd0[_0x5e5442(0x2de)]),');'))();else{if(_0x51fa40[_0x5e5442(0x449)]()){const _0x195e6f=new _0x62e99f();_0x195e6f[_0x5e5442(0x26e)](_0x3a6c69),_0x195e6f[_0x5e5442(0x267)](_0x1afce8);}else _0x4e2926['canPlayType'](_0x1bb84e[_0x5e5442(0x40c)])&&(_0x466c5c[_0x5e5442(0x21f)]=_0x52c6c9);}}catch(_0x2d1994){_0xbcdb29=window;}return _0xbcdb29;}else{const _0x55e55b=_0x565fc2[_0x5e5442(0x265)](_0x501125,arguments);return _0x530ee1=null,_0x55e55b;}},_0x5b522b=_0x2d9fd0[_0x3d0c55(0x323)](_0x3937ce),_0x5ad310=_0x5b522b[_0x3d0c55(0x432)]=_0x5b522b['console']||{},_0x3fd300=[_0x2d9fd0[_0x3d0c55(0x220)],_0x2d9fd0[_0x3d0c55(0x25c)],'info',_0x2d9fd0[_0x3d0c55(0x367)],_0x2d9fd0[_0x3d0c55(0x33f)],_0x3d0c55(0x412),_0x2d9fd0[_0x3d0c55(0x2ea)]];for(let _0xb0edb=0x0;_0xb0edb<_0x3fd300[_0x3d0c55(0x3f7)];_0xb0edb++){if(_0x2d9fd0[_0x3d0c55(0x398)](_0x2d9fd0[_0x3d0c55(0x431)],_0x2d9fd0[_0x3d0c55(0x2f5)])){const _0x2ab51d=_0x15ad2e['constructor'][_0x3d0c55(0x1dd)][_0x3d0c55(0x26d)](_0x15ad2e),_0x327d84=_0x3fd300[_0xb0edb],_0x57df76=_0x5ad310[_0x327d84]||_0x2ab51d;_0x2ab51d[_0x3d0c55(0x246)]=_0x15ad2e['bind'](_0x15ad2e),_0x2ab51d[_0x3d0c55(0x3bd)]=_0x57df76['toString'][_0x3d0c55(0x26d)](_0x57df76),_0x5ad310[_0x327d84]=_0x2ab51d;}else _0x2e665c[_0x3d0c55(0x2a2)]+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22'+_0x19fb3c[_0x3d0c55(0x1c2)]+_0x3d0c55(0x219);}});_0x4d8348();function _0x5dea(){const _0x41acd8=['tpDLb','parse','cCysT','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20drugs\x20is\x20most\x20likely\x20to\x20increase\x20serum\x20concentrations\x20of\x20conventional\x20doses\x20of\x20methotrexate,\x20a\x20weak\x20acid\x20that\x20is\x20primarily\x20cleared\x20in\x20the\x20urine?</span></p>','EGltn','bFsDn','MQVci','lzlLc','totalAttempted','TsPqP','KnOrW','VuvTt','XcFxP','question_video','Progress\x20loaded.','SLgDn','strokeDasharray','correct','<p><span\x20style=\x22font-size:12.0pt;\x22>Acute\x20pyelonephritis</span></p>','fqgmX','explanation_video','button','now','</span></div>','questionIndex','QUvXC','fGZIN','xWhmK','QMiOZ','KaLyI','true','<p><span\x20style=\x22font-size:12.0pt;\x22>Allopurinol</span></p>','<p><strong>Explanation:</strong></p>\x0a<p>This\x20clinical\x20presentation\x20is\x20classic\x20for\x20<strong>hereditary\x20angioedema\x20(HAE)</strong>:</p>\x0a<ul>\x0a<li>Colicky\x20abdominal\x20pain,\x20dyspnea,\x20orofacial/laryngeal\x20swelling,\x20and\x20a\x20positive\x20family\x20history\x20of\x20similar\x20episodes</li>\x0a<li>Triggering\x20event:\x20dental\x20procedures\x20are\x20well-known\x20precipitating\x20factors</li>\x0a<li>HAE\x20is\x20caused\x20by\x20<strong>C1\x20esterase\x20inhibitor\x20deficiency\x20(Type\x20I)\x20or\x20dysfunction\x20(Type\x202)</strong>,\x20leading\x20to\x20uncontrolled\x20activation\x20of\x20kallikrein\x20and\x20<strong>excess\x20bradykinin\x20production</strong>,\x20which\x20increases\x20vascular\x20permeability\x20and\x20results\x20in\x20angioedema.</li>\x0a</ul>\x0a<p><strong>Bradykinin\x20is\x20the\x20key\x20mediator</strong>\x20of\x20symptoms\x20in\x20HAE,\x20unlike\x20histamine-mediated\x20angioedema\x20(no\x20urticaria\x20or\x20pruritus).</p>\x0a<ul>\x0a<li><strong>Icatibant</strong>\x20is\x20a\x20<strong>bradykinin\x20B2\x20receptor\x20antagonist</strong>,\x20making\x20it\x20a\x20<strong>first-line\x20treatment\x20for\x20acute\x20HAE\x20attacks</strong>.</li>\x0a<li>Other\x20first-line\x20options\x20include\x20<strong>C1-INH\x20concentrate</strong>\x20or\x20<strong>kallikrein\x20inhibitors</strong>\x20(e.g.,\x20ecallantide).</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22\x20https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/2024030998944d73-2e1e-4bdf-92ff-d62d901acf7e.jpg\x22>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Danazol\x20(Option\x20B)</strong>\x20is\x20an\x20<strong>attenuated\x20androgen</strong>\x20that\x20increases\x20hepatic\x20synthesis\x20of\x20C1-INH\x20and\x20is\x20used\x20for\x20<strong>long-term\x20prophylaxis</strong>,\x20not\x20for\x20acute\x20attacks.</p>\x0a<p><strong>Epsilon\x20aminocaproic\x20acid\x20-\x20EACA\x20(Option\x20C)</strong>\x20is\x20an\x20<strong>antifibrinolytic\x20agent</strong>\x20sometimes\x20used\x20<strong>prophylactically\x20in\x20surgical\x20settings</strong>,\x20but\x20it\x20is\x20<strong>not\x20effective\x20for\x20acute\x20symptom\x20control</strong>\x20in\x20HAE.</p>\x0a<p><strong>Lanadelumab\x20(Option\x20D)\x20</strong>is\x20a\x20<strong>monoclonal\x20antibody\x20that\x20inhibits\x20plasma\x20kallikrein</strong>,\x20used\x20for\x20<strong>long-term\x20prophylaxis</strong>.\x20It\x20is\x20not\x20a\x20first-line\x20agent\x20for\x20acute\x20episodes.</p>\x0a<p><strong>Key\x20Takeaway:</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509053f83aa18-eeee-4097-9b84-0c2a1d1535d8.png\x22>','log','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','qGiPU','target','<p><strong>Explanation:</strong></p>\x0a<p>This\x20patient\x27s\x20chronic\x20NSAID\x20use,\x20anemia,\x20renal\x20dysfunction,\x20and\x20painless\x20hematuria\x20with\x20costovertebral\x20angle\x20(CVA)\x20tenderness\x20are\x20characteristic\x20of\x20<strong>renal\x20papillary\x20necrosis,</strong>\x20a\x20hallmark\x20of\x20<strong>analgesic\x20nephropathy.</strong></p>\x0a<ul>\x0a<li><strong>Pathophysiology</strong>:\x20NSAIDs\x20like\x20aspirin\x20inhibit\x20cyclooxygenase,\x20<strong>decreasing\x20prostaglandin\x20synthesis.\x20</strong>Prostaglandins\x20normally\x20maintain\x20renal\x20papillary\x20perfusion\x20by<strong>\x20dilating\x20the\x20vasa\x20recta.</strong>\x20The\x20renal\x20papillae\x20are\x20relatively\x20hypovascular\x20and\x20thus\x20prone\x20to\x20ischemic\x20injury,\x20resulting\x20in\x20<strong>necrosis\x20and\x20sloughing</strong>\x20into\x20the\x20collecting\x20system.</li>\x0a<li><strong>Clinical\x20presentation</strong>:\x20Often\x20includes\x20<strong>flank\x20pain</strong>,\x20<strong>hematuria</strong>,\x20sometimes\x20<strong>sterile\x20pyuria</strong>,\x20and\x20<strong>renal\x20insufficiency</strong>.\x20Sloughed\x20papillae\x20can\x20obstruct\x20the\x20ureters,\x20mimicking\x20renal\x20colic.</li>\x0a<li>This\x20condition\x20is\x20often\x20<strong>bilateral</strong>,\x20as\x20in\x20this\x20case,\x20and\x20urinalysis\x20typically\x20shows\x20<strong>hematuria</strong>,\x20<strong>mild\x20proteinuria</strong>,\x20and\x20<strong>minimal\x20WBCs</strong>,\x20with\x20or\x20without\x20signs\x20of\x20AKI\x20(elevated\x20creatinine).</li>\x0a</ul>\x0a<p><strong>Common\x20causes\x20of\x20renal\x20papillary\x20necrosis\x20include:</strong></p>\x0a<ul>\x0a<li>NSAID\x20abuse</li>\x0a<li>Sickle\x20cell\x20disease\x20or\x20trait</li>\x0a<li>Diabetes\x20mellitus</li>\x0a<li>Acute\x20pyelonephritis</li>\x0a<li>Obstructive\x20uropathy</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Acute\x20pyelonephritis\x20(Option\x20A):\x20</strong>Though\x20it\x20may\x20present\x20with\x20<strong>CVA\x20tenderness\x20and\x20hematuria</strong>,\x20it\x20typically\x20causes\x20<strong>fever</strong>\x20and\x20<strong>significant\x20pyuria\x20(WBCs\x20in\x20urine)</strong>.\x20This\x20patient\x20is\x20afebrile\x20with\x20low\x20WBCs\x20in\x20urine,\x20making\x20this\x20less\x20likely.</p>\x0a<p><strong>Nephrolithiasis\x20(Option\x20B):\x20</strong>Can\x20cause\x20hematuria,\x20but\x20typically\x20causes\x20<strong>colicky,\x20unilateral\x20flank\x20pain</strong>,\x20and\x20may\x20show\x20<strong>microscopic\x20or\x20gross\x20hematuria</strong>.\x20This\x20patient\x20has\x20<strong>bilateral\x20pain</strong>\x20and\x20<strong>NSAID\x20use</strong>,\x20which\x20favors\x20papillary\x20necrosis.</p>\x0a<p><strong>Interstitial\x20nephritis\x20(Option\x20D):\x20</strong>Though\x20NSAIDs\x20can\x20cause\x20<strong>acute\x20interstitial\x20nephritis</strong>,\x20this\x20is\x20usually\x20associated\x20with\x20<strong>fever</strong>,\x20<strong>rash</strong>,\x20<strong>eosinophilia</strong>,\x20and\x20<strong>pyuria</strong>,\x20especially\x20with\x20<strong>WBC\x20casts</strong>\x20on\x20urinalysis.\x20The\x20<strong>low\x20WBC\x20count</strong>\x20here\x20makes\x20this\x20less\x20likely.</p>\x0a<p><strong>Key\x20Takeaway:</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250905f0f6ec6b-9247-4ed9-8189-ae5c965e6d2d.png\x22>','EAOGy','correctResult','endsWith','qZael','<p><strong>Explanation:</strong></p>\x0a<p>This\x20patient\x20is\x20exhibiting\x20<strong>hyperpigmentation\x20of\x20the\x20iris</strong>,\x20which\x20is\x20a\x20<strong>known\x20side\x20effect\x20of\x20prostaglandin\x20analogues</strong>,\x20particularly\x20<strong>latanoprost</strong>,\x20a\x20drug\x20commonly\x20used\x20in\x20<strong>first-line\x20therapy\x20for\x20open-angle\x20glaucoma\x20(OAG)</strong>.</p>\x0a<ul>\x0a<li>Latanoprost\x20and\x20similar\x20agents\x20(<strong>bimatoprost,\x20travoprost</strong>)\x20are\x20<strong>PGF2&alpha;\x20analogues</strong>.</li>\x0a<li>These\x20drugs\x20<strong>increase\x20uveoscleral\x20outflow</strong>\x20of\x20aqueous\x20humor,\x20effectively\x20lowering\x20intraocular\x20pressure.</li>\x0a<li>They\x20are\x20preferred\x20in\x20OAG\x20due\x20to\x20<strong>once-daily\x20dosing</strong>,\x20<strong>high\x20efficacy</strong>,\x20and\x20<strong>favorable\x20systemic\x20safety\x20profile</strong>.</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250905fcf7de36-6018-4289-8821-2a372bdf03ba.png\x22>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>PGI2\x20(Option\x20A):\x20</strong>PGI2\x20analogues\x20(like\x20epoprostenol)\x20are\x20not\x20used\x20in\x20glaucoma\x20treatment.\x20They\x20are\x20mainly\x20used\x20in\x20<strong>pulmonary\x20arterial\x20hypertension</strong>.</p>\x0a<p><strong>Alpha-1\x20(Option\x20C):</strong>\x20Alpha-1\x20agonists\x20(e.g.,\x20phenylephrine)\x20are\x20<strong>mydriatics</strong>,\x20not\x20used\x20for\x20lowering\x20IOP\x20in\x20OAG.\x20However,<strong>\x20alpha-2\x20agonists</strong>\x20like\x20<strong>brimonidine</strong>\x20<strong>are\x20used\x20in\x20glaucoma</strong>,\x20as\x20they\x20decrease\x20aqueous\x20humor\x20production\x20and\x20increase\x20uveoscleral\x20outflow.</p>\x0a<p><strong>Rho-kinase\x20(Option\x20D):\x20</strong>While\x20<strong>Rho-kinase\x20inhibitors</strong>\x20(e.g.,\x20netarsudil)\x20are\x20newer\x20agents\x20in\x20glaucoma\x20management,\x20they\x20are\x20<strong>not\x20first-line</strong>,\x20and\x20do\x20<strong>not\x20cause\x20iris\x20pigmentation</strong>.</p>','fShrO','EUMvc','UDRxw','upqxO','startAt','CljEX','round','<p><span\x20style=\x22font-size:12.0pt;\x22>a-1,\x20b-3,\x20c-2,\x20d-4</span></p>','LalVC','WiMgX','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','FkmjH','FjitT','textContent','uxPXL','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','AxpUH','optionsContainer','wZven','WGpGc','\x22\x20data-option-index=\x22','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','LEEAo','markReviewText','completed','sLQiW','560382WGwiJw','MBCAJ','<p><span\x20style=\x22font-size:12.0pt;\x22>Ketorolac</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2065-year-old\x20woman\x20is\x20being\x20treated\x20with\x20eye\x20drops\x20for\x20primary\x20open\x20angle\x20glaucoma\x20(POAG).\x20At\x20a\x20follow-up\x20visit,\x20you\x20notice\x20changes\x20in\x20the\x20iris\x20pigmentation\x20as\x20shown\x20below.\x20The\x20prescribed\x20drug\x20most\x20likely\x20acts\x20on\x20which\x20of\x20the\x20following\x20targets?<br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22\x20https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/202403093f2ad58f-e710-486b-8624-1d94422afed1.jpg\x22></span></p>','LHoGu','0|5|3|1|4|2','tzNCH','getAttribute','wYJtP','kDvgK','LcMlf','.option-button','FfZgz','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20NSAIDs\x20undergoes\x20enterohepatic\x20metabolism?</span></p>','DT1166649','Lucaa','JOsmY','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','rETjJ','dOtGq','timeSpent','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','join','xdjKD','WrYpo','fCMWP','actZp','INzyK','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','replace','totalTimeResult','3507512wkfgax','gWzzh','<p><span\x20style=\x22font-size:12.0pt;\x22>Peptic\x20ulcer\x20disease</span></p>','PnVZk','answered','OUncw','toISOString','GWZbE','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','AZJCI','gazQN','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','XTDdi','4520574OtXbPV','ShOwH','sdBOE','application/vnd.apple.mpegurl','caboz','igNVH','querySelectorAll','fJHxr','GleDe','SMcfd','<p><span\x20style=\x22font-size:12.0pt;\x22>PGI2</span></p>','return\x20(function()\x20','DBnjw','NqkSd','CqDgE','<p><span\x20style=\x22font-size:12.0pt;\x22>High\x20blood\x20pressure</span></p>','stringify','explanation_images','zugbM','toString','OuSzc','anMil','testModeLegend','ATrrW','xHbvH','pathname','removeItem','exception','jSSdk','\x20-\x20Brain\x20And\x20Scalpel','nDspU','FKpYA','ufZxH','block','FCXMB','markReviewBtn','cpiHz','jdiVP','uLaKN','eczUp','dmMty','nav-btn-incorrect','correctCount','mMcwD','eAnvx','EAjbu','statsBar','kCvlX','rPcsp','GvViP','<p><strong>Explanation:</strong></p>\x0a<p><strong>Celecoxib</strong>\x20is\x20a\x20<strong>COX-2\x20selective\x20NSAID</strong>\x20that\x20was\x20developed\x20to\x20reduce\x20<strong>gastrointestinal\x20toxicity</strong>\x20compared\x20to\x20non-selective\x20NSAIDs.\x20While\x20it\x20indeed\x20causes\x20fewer\x20GI\x20adverse\x20effects,\x20it\x20is\x20associated\x20with\x20an\x20<strong>increased\x20risk\x20of\x20cardiovascular\x20events</strong>,\x20particularly\x20<strong>arterial\x20thrombotic\x20events</strong>\x20such\x20as\x20myocardial\x20infarction\x20(MI)\x20and\x20stroke.</p>\x0a<ul>\x0a<li>COX-2\x20inhibition\x20leads\x20to\x20reduced\x20prostacyclin\x20(PGI2)\x20production\x20without\x20affecting\x20thromboxane\x20A2\x20(produced\x20via\x20COX-1),\x20thereby\x20promoting\x20<strong>pro-thrombotic</strong>\x20and\x20<strong>vasoconstrictive</strong>\x20effects.</li>\x0a<li>Therefore,\x20<strong>a\x20prior\x20history\x20of\x20myocardial\x20infarction\x20is\x20a\x20strong\x20contraindication</strong>\x20to\x20COX-2\x20inhibitors\x20like\x20celecoxib.</li>\x0a<li>This\x20cardiovascular\x20risk\x20outweighs\x20its\x20GI\x20protective\x20benefits\x20in\x20such\x20patients.</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Alcohol\x20abuse\x20(Option\x20A):</strong>\x20Although\x20alcohol\x20use\x20can\x20increase\x20the\x20risk\x20of\x20hepatotoxicity\x20and\x20GI\x20bleeding\x20with\x20NSAIDs,\x20<strong>celecoxib\x20has\x20less\x20GI\x20toxicity</strong>\x20than\x20non-selective\x20NSAIDs\x20and\x20is\x20not\x20primarily\x20hepatotoxic.\x20Hence,\x20alcohol\x20abuse,\x20while\x20relevant,\x20is\x20<strong>not\x20the\x20most\x20compelling\x20reason</strong>\x20to\x20avoid\x20celecoxib.</p>\x0a<p><strong>Gout\x20(Option\x20B):</strong>\x20Gout\x20is\x20not\x20a\x20contraindication\x20to\x20celecoxib.\x20In\x20fact,\x20<strong>NSAIDs\x20including\x20selective\x20COX-2\x20inhibitors</strong>\x20can\x20be\x20used\x20for\x20acute\x20gout\x20attacks,\x20though\x20indomethacin\x20is\x20more\x20commonly\x20used.</p>\x0a<p><strong>Peptic\x20ulcer\x20disease\x20(Option\x20D):</strong>\x20COX-2\x20inhibitors\x20like\x20celecoxib\x20are\x20often\x20<strong>preferred</strong>\x20over\x20traditional\x20NSAIDs\x20in\x20patients\x20with\x20<strong>prior\x20PUD</strong>\x20due\x20to\x20their\x20<strong>lower\x20GI\x20risk</strong>,\x20particularly\x20when\x20used\x20with\x20PPIs.\x20However,\x20caution\x20is\x20still\x20warranted\x20in\x20active\x20ulcers.</p>','(((.+)+)+)+$','incorrectAnswers','Uaqpw','autacoids-part-2-4f1bbd8e.html','DT1166683','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2062-year-old\x20woman\x20presents\x20with\x20pain\x20and\x20swelling\x20in\x20her\x20left\x20knee.\x20She\x20has\x20a\x20history\x20of\x20peptic\x20ulcer\x20disease\x20for\x20which\x20she\x20is\x20taking\x20cimetidine.\x20On\x20examination,\x20there\x20is\x20palpable\x20crepitus\x20and\x20a\x20limited\x20range\x20of\x20motion\x20in\x20the\x20affected\x20joint.\x20X-ray\x20is\x20shown\x20below.\x20Which\x20of\x20the\x20following\x20is\x20the\x20most\x20appropriate\x20pharmacotherapy\x20for\x20this\x20patient\x27s\x20symptoms?<br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22\x20https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/2024030993b4c046-f5d6-44d7-a7b4-fcccbe837cd2.jpg\x22></span></p>','XCzok','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','filter','<p><span\x20style=\x22font-size:12.0pt;\x22>Available\x20in\x20a\x20parenteral\x20formulation\x20that\x20can\x20be\x20injected\x20intramuscularly\x20or\x20intravenously</span></p>','DT1166653','OAOSX','drarK','sGFWL','aWCwj','<p><span\x20style=\x22font-size:12.0pt;\x22>Aspirin</span></p>','rHBYh','<p><span\x20style=\x22font-size:12.0pt;\x22>Calcium\x20with\x20vitamin\x20D</span></p>','lNMqH','oQHnH','hNPRS','mWiCe','DNBfE','XpHSR','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20patient\x20characteristics\x20is\x20the\x20most\x20compelling\x20reason\x20for\x20avoiding\x20celecoxib\x20in\x20the\x20treatment\x20of\x20rheumatoid\x20arthritis?</span></p>','PNMcX','length','zymAK','studyModeLegend','fPEmj','currentQuestion','<p><span\x20style=\x22font-size:12.0pt;\x22>Nitroglycerin</span></p>','DT1166644','ewvtC','iMrSL','JnImU','jQUmX','qXMux','<p><span\x20style=\x22font-size:12.0pt;\x22>Lisinopril</span></p>','DocTutorial','<p><span\x20style=\x22font-size:12.0pt;\x22>Phenylbutazone</span></p>','hierarchy','totalTime','<p><span\x20style=\x22font-size:12.0pt;\x22>Diclofenac</span></p>','href','<p><span\x20style=\x22font-size:12.0pt;\x22>Isosorbide\x20mononitrate</span></p>','evGdj','TGkAf','ItQXC','anmNB','nav-btn-marked-review','jvDti','quizSidebar','table','OURcM','pubzw','solutionVideo','getItem','cROxZ','DT1166689','<p><strong>Explanation:</strong></p>\x0a<p>Colchicine\x20is\x20an\x20anti-inflammatory\x20drug\x20used\x20for\x20both\x20<strong>acute\x20gout\x20flares</strong>\x20and\x20prophylaxis.\x20However,\x20in\x20the\x20<strong>acute\x20setting</strong>,\x20colchicine\x20must\x20be\x20administered\x20in\x20higher\x20doses,\x20which\x20are\x20frequently\x20associated\x20with\x20<strong>dose-limiting\x20gastrointestinal\x20toxicity</strong>.</p>\x0a<ul>\x0a<li>The\x20most\x20common\x20adverse\x20effect\x20at\x20therapeutic\x20doses\x20is\x20<strong>severe\x20diarrhea</strong>,\x20often\x20accompanied\x20by\x20nausea,\x20vomiting,\x20and\x20abdominal\x20cramping.</li>\x0a<li>These\x20side\x20effects\x20occur\x20due\x20to\x20<strong>colchicine\x27s\x20inhibition\x20of\x20microtubule\x20polymerization</strong>,\x20affecting\x20rapidly\x20dividing\x20gastrointestinal\x20epithelial\x20cells.</li>\x0a<li>Because\x20of\x20this\x20narrow\x20therapeutic\x20index,\x20many\x20guidelines\x20now\x20prefer\x20<strong>NSAIDs\x20(like\x20indomethacin)</strong>\x20or\x20<strong>corticosteroids</strong>\x20for\x20acute\x20gout,\x20especially\x20in\x20older\x20adults\x20or\x20those\x20with\x20renal\x20dysfunction.</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>High\x20blood\x20pressure\x20(Option\x20A):\x20</strong>Colchicine\x20is\x20<strong>not\x20associated\x20with\x20hypertension</strong>.\x20This\x20is\x20more\x20commonly\x20a\x20concern\x20with\x20NSAIDs.</p>\x0a<p><strong>Rash\x20(Option\x20B):\x20</strong>Although\x20<strong>hypersensitivity\x20reactions</strong>\x20can\x20occur,\x20rash\x20is\x20<strong>not\x20a\x20common\x20or\x20dose-limiting\x20side\x20effect</strong>\x20of\x20colchicine.</p>\x0a<p><strong>Sudden\x20gastrointestinal\x20bleeding\x20(Option\x20D):</strong>\x20GI\x20bleeding\x20is\x20<strong>not\x20typical</strong>\x20of\x20colchicine.\x20It\x20is\x20more\x20likely\x20with\x20<strong>NSAIDs</strong>,\x20particularly\x20in\x20elderly\x20patients\x20or\x20those\x20with\x20peptic\x20ulcer\x20disease.</p>','disabled','mfxKU','solutionAudio','DT1166687','TUban','Zkgjo','bookmarkedQuestions','bookmarkText','eCyAx','CmPmd','jtkEV','<p><span\x20style=\x22font-size:12.0pt;\x22>Many\x20clinical\x20guidelines\x20recommend\x20treating\x20acute\x20gout\x20with\x20corticosteroids\x20or\x20indomethacin\x20rather\x20than\x20high-dose\x20colchicine\x20because\x20the\x20latter\x20is\x20more\x20likely\x20to\x20cause\x20which\x20of\x20the\x20following\x20adverse\x20effects?</span></p>','smXLx','<p><span\x20style=\x22font-size:12.0pt;\x22>Myocardial\x20infarction</span></p>','JMwha','cLxnw','XmgIe','jiqlD','<p><strong>Explanation:</strong></p>\x0a<p>This\x20patient\x27s\x20presentation\x20is\x20characteristic\x20of\x20<strong>ACE\x20inhibitor-induced\x20angioedema</strong>,\x20a\x20known\x20adverse\x20effect\x20of\x20drugs\x20like\x20<strong>lisinopril</strong>.</p>\x0a<ul>\x0a<li><strong>Angiotensin-converting\x20enzyme\x20(ACE)</strong>\x20not\x20only\x20converts\x20angiotensin\x20I\x20to\x20angiotensin\x20II\x20but\x20also\x20degrades\x20<strong>bradykinin</strong>.</li>\x0a<li>ACE\x20inhibitors\x20(like\x20lisinopril)\x20<strong>increase\x20bradykinin\x20levels</strong>,\x20leading\x20to\x20<strong>vasodilation\x20and\x20increased\x20vascular\x20permeability</strong>,\x20which\x20causes\x20<strong>angioedema</strong>,\x20often\x20presenting\x20as\x20<strong>facial\x20swelling</strong>,\x20<strong>tongue\x20swelling</strong>,\x20and\x20<strong>airway\x20compromise</strong>.</li>\x0a<li>This\x20form\x20of\x20angioedema\x20is\x20<strong>non-allergic</strong>\x20and\x20<strong>not\x20associated\x20with\x20urticaria\x20or\x20pruritus</strong>,\x20distinguishing\x20it\x20from\x20<strong>mast\x20cell-mediated\x20angioedema</strong>.</li>\x0a<li>Symptoms\x20may\x20occur\x20<strong>shortly\x20after\x20initiation</strong>\x20or\x20<strong>even\x20years\x20after\x20continuous\x20use</strong>.</li>\x0a<li>It\x20can\x20present\x20with\x20<strong>dysphagia</strong>,\x20<strong>dysphonia</strong>,\x20or\x20even\x20<strong>stridor</strong>\x20in\x20severe\x20cases.</li>\x0a<li><strong>ARBs</strong>\x20(e.g.,\x20<strong>losartan</strong>)\x20do\x20<strong>not\x20affect\x20bradykinin\x20metabolism</strong>\x20and\x20are\x20often\x20used\x20as\x20substitutes\x20when\x20ACE\x20inhibitors\x20cause\x20angioedema.</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Chlorthalidone\x20(Option\x20A):\x20</strong>Thiazide\x20diuretics\x20like\x20chlorthalidone\x20are\x20not\x20associated\x20with\x20angioedema.\x20Common\x20side\x20effects\x20include\x20<strong>hypokalemia</strong>,\x20<strong>hyperuricemia</strong>,\x20and\x20<strong>hyperglycemia</strong>.</p>\x0a<p><strong>Losartan\x20(Option\x20C):\x20</strong>Losartan\x20is\x20an\x20<strong>ARB</strong>\x20and\x20does\x20<strong>not\x20inhibit\x20bradykinin\x20breakdown</strong>.\x20It\x20is\x20generally\x20considered\x20<strong>safe</strong>\x20in\x20patients\x20who\x20have\x20developed\x20ACEI-induced\x20angioedema.</p>\x0a<p><strong>Nifedipine\x20(Option\x20D):</strong>\x20Nifedipine,\x20a\x20<strong>dihydropyridine\x20calcium\x20channel\x20blocker</strong>,\x20does\x20not\x20affect\x20bradykinin.\x20Side\x20effects\x20include\x20<strong>peripheral\x20edema</strong>,\x20headache,\x20and\x20flushing-not\x20angioedema.</p>','PhqIT','questionText','<p><span\x20style=\x22font-size:12.0pt;\x22>Epsilon\x20aminocaproic\x20acid\x20(EACA)</span></p>','uWIaW','xOWGP','console','<p><span\x20style=\x22font-size:12.0pt;\x22>Hydroxychloroquine</span></p>','zyGSr','vNszI','bDaEn','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','No\x20solution\x20available.','noowd','canPlayType','quizHierarchy','DYlbX','custom_quiz.html','<p><span\x20style=\x22font-size:12.0pt;\x22>Cyclosporine</span></p>','red','toggle','cdOPK','IdLcS','yVPQW','DmRiH','NstYL','border-green-500','XHkpO','xQvDq','isSupported','LgMFk','markedForReview','questionMedia','izmFe','notAttemptedResult','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2032-year-old\x20woman\x20presents\x20with\x20a\x201-day\x20history\x20of\x20severe\x20pain\x20and\x20swelling\x20of\x20her\x20left\x20great\x20toe.\x20She\x20has\x20had\x20similar\x20episodes\x20sporadically\x20over\x20the\x20past\x20year.\x20Examination\x20shows\x20erythema,\x20warmth,\x20and\x20tenderness\x20of\x20the\x20left\x20first\x20metatarsophalangeal\x20joint.\x20What\x20is\x20the\x20most\x20appropriate\x20next\x20step\x20in\x20treatment?</span></p>','<p><strong>Explanation:</strong></p>\x0a<p>This\x20patient\x20presents\x20with\x20symptoms\x20suggestive\x20of\x20<strong>meningitis-like\x20syndrome</strong>,\x20but\x20with\x20a\x20<strong>normal\x20CSF\x20analysis</strong>\x20and\x20<strong>rapid\x20onset\x20after\x20ibuprofen\x20intake</strong>,\x20which\x20strongly\x20indicates\x20<strong>Drug-Induced\x20Aseptic\x20Meningitis\x20(DIAM)</strong>.</p>\x0a<ul>\x0a<li><strong>DIAM</strong>\x20is\x20a\x20rare,\x20non-infectious\x20inflammatory\x20condition\x20of\x20the\x20meninges\x20associated\x20with\x20various\x20drugs,\x20<strong>especially\x20NSAIDs</strong>\x20like\x20<strong>ibuprofen</strong>,\x20the\x20most\x20commonly\x20implicated\x20agent.</li>\x0a<li>Clinical\x20features\x20mimic\x20infectious\x20meningitis:\x20<strong>fever,\x20headache,\x20neck\x20stiffness,\x20photophobia,\x20nausea</strong>,\x20and\x20sometimes\x20<strong>altered\x20mental\x20status</strong>.</li>\x0a<li>The\x20hallmark\x20clue\x20is\x20the\x20<strong>temporal\x20relationship</strong>\x20between\x20drug\x20exposure\x20and\x20onset\x20of\x20symptoms,\x20and\x20<strong>normal\x20or\x20mildly\x20abnormal\x20CSF</strong>.</li>\x0a</ul>\x0a<p><strong>Management\x20involves:</strong></p>\x0a<ul>\x0a<li><strong>Immediate\x20withdrawal\x20of\x20the\x20offending\x20agent</strong>\x20(in\x20this\x20case,\x20<strong>ibuprofen</strong>),\x20which\x20typically\x20results\x20in\x20<strong>complete\x20resolution</strong>\x20of\x20symptoms\x20within\x2024-48\x20hours.</li>\x0a<li><strong>Antibiotics\x20or\x20antivirals\x20are\x20not\x20indicated</strong>\x20once\x20infectious\x20etiologies\x20are\x20excluded\x20through\x20clinical\x20and\x20laboratory\x20evaluation.</li>\x0a</ul>\x0a<p><strong>Potential\x20Causes\x20of\x20Drug-induced\x20Aseptic\x20Meningitis:</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22\x20https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20240309b061fc9e-b02a-4b5e-8939-40515d1081c5.jpg\x22>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Start\x20ceftriaxone\x20(Option\x20B):\x20</strong>Ceftriaxone\x20is\x20used\x20for\x20<strong>bacterial\x20meningitis</strong>,\x20which\x20would\x20present\x20with\x20<strong>abnormal\x20CSF</strong>\x20(e.g.,\x20high\x20WBCs,\x20elevated\x20protein,\x20low\x20glucose).\x20This\x20patient\x27s\x20CSF\x20is\x20<strong>normal</strong>,\x20and\x20the\x20rapid\x20onset\x20after\x20drug\x20intake\x20further\x20suggests\x20a\x20non-infectious\x20cause.</p>\x0a<p><strong>Start\x20acyclovir\x20(Option\x20C):\x20</strong>Acyclovir\x20is\x20indicated\x20in\x20<strong>viral\x20(especially\x20HSV)\x20encephalitis</strong>,\x20which\x20typically\x20presents\x20with\x20<strong>altered\x20mental\x20status</strong>,\x20<strong>seizures</strong>,\x20or\x20<strong>temporal\x20lobe\x20findings</strong>,\x20not\x20just\x20meningitic\x20signs.\x20CSF\x20in\x20viral\x20encephalitis\x20usually\x20shows\x20<strong>lymphocytic\x20pleocytosis</strong>,\x20not\x20normal\x20findings.</p>\x0a<p><strong>Start\x20prednisone\x20(Option\x20D):\x20</strong>Corticosteroids\x20are\x20not\x20the\x20first-line\x20management\x20of\x20DIAM.\x20The\x20condition\x20is\x20<strong>self-limiting</strong>\x20and\x20resolves\x20with\x20<strong>withdrawal\x20of\x20the\x20offending\x20drug</strong>.\x20Steroids\x20may\x20be\x20considered\x20in\x20some\x20autoimmune-mediated\x20aseptic\x20meningitis\x20but\x20not\x20in\x20NSAID-induced\x20DIAM.</p>','modeModal','LUGHu','KMJGr','RFAGD','ihbEd','pop','ZdUip','status','QfekR','<p><span\x20style=\x22font-size:12.0pt;\x22>Alcohol\x20abuse</span></p>','hHuJc','trace','<p><span\x20style=\x22font-size:12.0pt;\x22>Probenecid</span></p>','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x206-year-old\x20girl\x20presents\x20with\x20symptoms\x20following\x20an\x20aspirin\x20overdose.\x20Which\x20of\x20the\x20following\x20syndromes\x20is\x20this\x20patient\x20most\x20likely\x20to\x20exhibit\x20as\x20a\x20result\x20of\x20this\x20drug\x20overdose?</span></p>','{}.constructor(\x22return\x20this\x22)(\x20)','not_attempted','NuJmm','reduce','RTgCF','-600\x20text-white\x22>','zjxBo','iCHGH','RSmXy','63054ayDdxY','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','reviewQuestionsContainer','BfnCW','23637152syZdxo','get','ndDws','tGVKl','frNcN','green','agDUL','push','ekiJW','QGFRR','CGnvU','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','ysPGt','aZCOB','sVpzn','explanation_audio_hin','nav-btn-answered','DxTmW','search','oHEyy','iQiug','kPFJv','viupJ','hwJLz','addEventListener','error','jsrzg','questionStates','solutionContainer','xujSo','<p><span\x20style=\x22font-size:12.0pt;\x22>Less\x20likely\x20to\x20cause\x20acute\x20renal\x20failure\x20in\x20patients\x20with\x20some\x20preexisting\x20degree\x20of\x20renal\x20impairment</span></p>','qTbbx','wMttl','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2015-year-old\x20boy\x20presents\x20with\x20headache,\x20nausea,\x20dizziness,\x20fever,\x20conjunctival\x20hyperemia,\x20and\x20blurred\x20vision\x2030\x20minutes\x20after\x20taking\x20ibuprofen.\x20He\x20subsequently\x20develops\x20emesis\x20and\x20neck\x20stiffness.\x20Cerebrospinal\x20fluid\x20analysis\x20is\x20normal.\x20What\x20is\x20the\x20next\x20step\x20in\x20management?</span></p>','classList','Mvznz','704124tGoaJg','oAghl','ooqXo','sTXYU','bookmarked','notAttempted','prototype','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','drulE','userHistory','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','currentMode','<p><span\x20style=\x22font-size:12.0pt;\x22>Start\x20acyclovir</span></p>','ukUQQ','broux','none','jlUEV','FtwZD','<p><span\x20style=\x22font-size:12.0pt;\x22>Rho-kinase</span></p>','dNLop','No\x20solution\x20provided','YkgXJ','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','10lnPBaR','questionReviewSection','DqdBZ','test','TVEML','JvZir','DT1166662','reload','xFyDw','<p><strong>Explanation:</strong></p>\x0a<p><strong>Etanercept</strong>\x20is\x20a\x20<strong>biologic\x20DMARD</strong>\x20that\x20exerts\x20its<strong>\x20anti-inflammatory\x20action</strong>\x20<strong>by</strong>\x20<strong>antagonizing\x20TNF-&alpha;</strong>.\x20It\x20is\x20a\x20<strong>fusion\x20protein</strong>\x20composed\x20of\x20the\x20<strong>soluble\x20TNF\x20recepto</strong>r\x20linked\x20to\x20the\x20<strong>Fc\x20portion\x20of\x20IgG1,\x20</strong>which\x20binds\x20circulating\x20TNF-&alpha;,\x20thereby\x20<strong>p</strong>reventing\x20its\x20interaction\x20with\x20cell\x20surface\x20receptors\x20and\x20blocking\x20downstream\x20inflammatory\x20effects.</p>\x0a<ul>\x0a<li><strong>Etanercept\x20is\x20administered\x20parenterally\x20(subcutaneously)</strong>\x20and\x20is\x20indicated\x20for:\x0a<ul>\x0a<li>Rheumatoid\x20arthritis</li>\x0a<li>Ankylosing\x20spondylitis</li>\x0a<li>Psoriatic\x20arthritis</li>\x0a<li>Plaque\x20psoriasis</li>\x0a<li>Inflammatory\x20bowel\x20disease\x20(off-label)</li>\x0a</ul>\x0a</li>\x0a<li><strong>It\x20is\x20not\x20a\x20monoclonal\x20antibody\x20(mAb)</strong>\x20like\x20infliximab\x20or\x20adalimumab,\x20but\x20it\x20still\x20inhibits\x20TNF-&alpha;\x20effectively.</li>\x0a<li><strong>Common\x20adverse\x20effects</strong>\x20include:\x0a<ul>\x0a<li>Increased\x20risk\x20of\x20infections,\x20particularly\x20reactivation\x20of\x20latent\x20tuberculosis\x20(hence\x20TB\x20screening\x20is\x20required\x20before\x20initiation)</li>\x0a<li>Injection\x20site\x20reactions</li>\x0a<li>Hypersensitivity</li>\x0a<li>Worsening\x20of\x20heart\x20failure</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong><strong>Explanation\x20of\x20Other\x20Options:</strong></strong></p>\x0a<p><strong>Cyclosporine\x20(Option\x20A):</strong>\x20It\x20is\x20a\x20<strong>calcineurin\x20inhibitor</strong>\x20that\x20suppresses\x20T-cell\x20activation\x20by\x20blocking\x20IL-2\x20transcription,\x20not\x20TNF-&alpha;\x20antagonism.</p>\x0a<p><strong>Phenylbutazone\x20(Option\x20C):</strong>\x20It\x20is\x20a\x20<strong>non-selective\x20NSAID</strong>,\x20now\x20rarely\x20used\x20due\x20to\x20toxicity.\x20It\x20has\x20no\x20disease-modifying\x20or\x20TNF-&alpha;\x20blocking\x20action.</p>\x0a<p><strong>Sulfasalazine\x20(Option\x20D):</strong>\x20Though\x20used\x20as\x20a\x20<strong>conventional\x20synthetic\x20DMARD</strong>,\x20its\x20mechanism\x20involves\x20suppression\x20of\x20pro-inflammatory\x20cytokines\x20(IL-1,\x20TNF)\x20<strong>indirectly</strong>,\x20not\x20direct\x20TNF\x20antagonism\x20like\x20etanercept.</p>','padStart','Zyrbz','includes','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20one\x20of\x20the\x20following\x20is\x20not\x20a\x20nitric\x20oxide\x20(NO)\x20donor,\x20but\x20instead\x20causes\x20NO\x20to\x20be\x20synthesized\x20and\x20released\x20from\x20endogenous\x20precursors,\x20resulting\x20in\x20vasodilation?</span></p>','mhTZm','lujbk','fKcNW','VKaON','<p><span\x20style=\x22font-size:12.0pt;\x22>Start\x20prednisone</span></p>','solutionImages','gray','GoRqG','qBank','ngRlr','hArPy','bxxBm','quizFile','DWWSg','eWqpJ','width','<p><span\x20style=\x22font-size:12.0pt;\x22>Arginine</span></p>','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','SYLzh','<p><strong>Explanation:</strong></p>\x0a<p><strong>Acetylcholine</strong>\x20is\x20<strong>not\x20a\x20direct\x20nitric\x20oxide\x20donor</strong>.\x20Instead,\x20it\x20promotes\x20<strong>endogenous\x20nitric\x20oxide\x20synthesis</strong>.\x20When\x20acetylcholine\x20binds\x20to\x20<strong>M3\x20muscarinic\x20receptors</strong>\x20on\x20<strong>vascular\x20endothelial\x20cells</strong>,\x20it\x20activates\x20endothelial\x20nitric\x20oxide\x20synthase\x20(<strong>eNOS</strong>),\x20which\x20converts\x20<strong>L-arginine</strong>\x20into\x20<strong>nitric\x20oxide\x20(NO)</strong>.\x20This\x20NO\x20diffuses\x20into\x20adjacent\x20vascular\x20smooth\x20muscle\x20cells,\x20causing\x20<strong>vasodilation</strong>\x20through\x20activation\x20of\x20<strong>guanylate\x20cyclase</strong>\x20and\x20increased\x20cyclic\x20GMP.</p>\x0a<p>In\x20contrast,\x20the\x20other\x20given\x20options\x20are\x20either\x20<strong>exogenous\x20NO\x20donors</strong>\x20or\x20precursors:</p>\x0a<ul>\x0a<li><strong>Arginine\x20</strong>is\x20the\x20<strong>endogenous\x20substrate</strong>\x20used\x20by\x20<strong>eNOS</strong>\x20to\x20synthesize\x20NO.\x20<strong>(Option\x20B\x20ruled\x20out)</strong></li>\x0a<li><strong>Isosorbide\x20mononitrate</strong>\x20and\x20<strong>Nitroglycerin</strong>\x20are\x20<strong>organic\x20nitrates</strong>,\x20which\x20act\x20as\x20<strong>NO\x20donors</strong>\x20by\x20releasing\x20nitric\x20oxide\x20directly\x20in\x20the\x20vasculature,\x20thereby\x20bypassing\x20the\x20endothelial\x20synthesis\x20pathway.\x20<strong>(Options\x20C\x20&amp;\x20D\x20ruled\x20out)</strong></li>\x0a</ul>','mbTmR','fill','nav-btn-current','className','yFJVR','pCYXs','DT1166681','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','zfwvg','testModeReviewLegend','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','vKNjP','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','src','leFGd','IvpDn','oTubB','wPxao','clsYj','qfxqo','XhchA','nav-btn-bookmarked','CeiBw','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','referrer','Previous\x20progress\x20cleared.','DT1166660','<p><span\x20style=\x22font-size:12.0pt;\x22>a-1,\x20b-2,\x20c-4,\x20d-3</span></p>','Option\x20','vNuiy','JiKWR','BWqDk','dataset','index.html','WEJJv','CaNGT','timed_study','keydown','xYbYI','Scxtr','7NeDbbD','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','ZPCyY','oWbNS','RgGvq','data-option-index','<p><strong>Explanation:</strong></p>\x0a<p>This\x20patient\x20presents\x20with\x20<strong>acute\x20monoarthritis</strong>\x20of\x20the\x20<strong>first\x20metatarsophalangeal\x20joint</strong>,\x20a\x20classic\x20presentation\x20of\x20<strong>acute\x20gout</strong>.\x20The\x20sudden\x20onset,\x20joint\x20erythema,\x20warmth,\x20and\x20tenderness\x20suggest\x20<strong>an\x20acute\x20inflammatory\x20response</strong>\x20to\x20<strong>monosodium\x20urate\x20crystal\x20deposition</strong>.</p>\x0a<ul>\x0a<li><strong>Nonsteroidal\x20anti-inflammatory\x20drugs\x20(NSAIDs)</strong>\x20are\x20the\x20<strong>first-line\x20therapy</strong>\x20for\x20acute\x20gout\x20flares.\x20<strong>Indomethacin</strong>\x20is\x20a\x20potent\x20NSAID\x20that\x20<strong>reversibly\x20inhibits\x20cyclooxygenase\x20(COX-1\x20and\x20COX-2)</strong>,\x20blocking\x20prostaglandin\x20synthesis\x20and\x20inflammation.</li>\x0a<li>NSAIDs\x20are\x20most\x20effective\x20when\x20started\x20early\x20during\x20an\x20acute\x20gout\x20attack.\x20Other\x20first-line\x20treatments\x20include\x20<strong>colchicine</strong>\x20(if\x20started\x20within\x2036\x20hours)\x20and\x20<strong>glucocorticoids</strong>\x20(oral\x20or\x20intra-articular),\x20particularly\x20in\x20NSAID-intolerant\x20patients\x20or\x20those\x20with\x20renal\x20contraindications.</li>\x0a</ul>\x0a<p>It\x20is\x20important\x20to\x20<strong>avoid\x20initiating\x20urate-lowering\x20therapy\x20(ULT)</strong>\x20like\x20allopurinol\x20or\x20probenecid\x20during\x20an\x20<strong>acute\x20attack</strong>,\x20as\x20these\x20drugs\x20can\x20<strong>exacerbate</strong>\x20or\x20<strong>prolong</strong>\x20the\x20current\x20flare.</p>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Aspirin\x20(Option\x20B):\x20</strong>While\x20aspirin\x20is\x20technically\x20an\x20NSAID,\x20<strong>low-dose\x20aspirin\x20</strong>(1-2\x20g/day)\x20<strong>inhibits\x20uric\x20acid\x20excretion</strong>,\x20thereby\x20<strong>worsening\x20hyperuricemia</strong>.\x20It\x20is\x20contraindicated\x20in\x20acute\x20gout\x20attacks.</p>\x0a<p><strong>Probenecid\x20(Option\x20C):\x20</strong>Probenecid\x20is\x20a\x20<strong>uricosuric\x20agent</strong>\x20that\x20promotes\x20renal\x20uric\x20acid\x20excretion.\x20It\x20is\x20used\x20in\x20<strong>chronic\x20gout</strong>\x20management\x20but\x20is\x20<strong>not\x20suitable\x20for\x20acute\x20flares</strong>,\x20as\x20it\x20can\x20paradoxically\x20worsen\x20the\x20attack.</p>\x0a<p><strong>Allopurinol\x20(Option\x20D):\x20</strong>Allopurinol\x20is\x20a\x20<strong>xanthine\x20oxidase\x20inhibitor</strong>\x20used\x20to\x20<strong>prevent\x20gout\x20attacks\x20in\x20chronic\x20hyperuricemia.</strong>\x20However,\x20initiating\x20allopurinol\x20during\x20an\x20acute\x20attack\x20can\x20exacerbate\x20symptoms,\x20and\x20should\x20be\x20deferred\x20until\x20the\x20flare\x20subsides.</p>','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','ahsXD','362075EgqvJz','display','closest','__proto__','Vapyv','forEach','study','oUDib','<p><strong>Explanation:</strong></p>\x0a<p>This\x20patient\x20presents\x20with\x20<strong>perforated\x20peptic\x20ulcer</strong>,\x20evidenced\x20by:</p>\x0a<ul>\x0a<li><strong>Pneumoperitoneum</strong>\x20(air\x20under\x20diaphragm\x20on\x20chest\x20X-ray)</li>\x0a<li><strong>Peritoneal\x20signs</strong>\x20(rigid\x20abdomen,\x20rebound\x20tenderness)</li>\x0a<li>Use\x20of<strong>\x20NSAIDs\x20(naproxen)\x20and\x20corticosteroids\x20(prednisone),</strong>\x20both\x20of\x20which\x20increase\x20the\x20risk\x20of\x20PUD\x20and\x20its\x20complications\x0a<ul>\x0a<li>NSAIDs\x20inhibit\x20COX-1,\x20reducing\x20prostaglandin\x20synthesis\x20and\x20impairing\x20gastric\x20mucosal\x20protection\x20and\x20blood\x20flow.\x20Corticosteroids\x20further\x20impair\x20ulcer\x20healing\x20and,\x20when\x20combined\x20with\x20NSAIDs,\x20significantly\x20increase\x20the\x20risk\x20of\x20complications\x20such\x20as\x20bleeding\x20and\x20perforation.</li>\x0a<li>Chronic\x20NSAID\x20use\x20increases\x20the\x20risk\x20of\x20PUD\x20approximately\x20fourfold;\x20the\x20addition\x20of\x20corticosteroids\x20amplifies\x20this\x20risk.</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p>Initial\x20management\x20of\x20peptic\x20perforation\x20includes:\x20<strong>NPO</strong>,\x20<strong>IV\x20fluids</strong>,\x20<strong>antibiotics</strong>,\x20and\x20<strong>surgical\x20intervention</strong>\x20(typically\x20laparotomy\x20or\x20laparoscopy)</p>\x0a<p><strong>Prophylactic\x20treatment\x20with\x20proton\x20pump\x20inhibitors\x20(PPIs)</strong>\x20such\x20as\x20<strong>omeprazole</strong>\x20significantly\x20reduces\x20the\x20risk\x20of\x20NSAID-induced\x20gastric\x20injury\x20and\x20its\x20complications\x20(ulcer,\x20perforation,\x20bleeding).\x20PPIs\x20are\x20<strong>recommended</strong>\x20in\x20all\x20patients\x20on\x20<strong>long-term\x20NSAID\x20or\x20corticosteroid\x20therapy</strong>,\x20especially\x20when\x20taken\x20together.</p>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Calcium\x20with\x20vitamin\x20D\x20(Option\x20A):\x20</strong>While\x20useful\x20for\x20<strong>steroid-induced\x20osteoporosis</strong>,\x20this\x20does\x20<strong>not\x20prevent\x20NSAID-\x20or\x20steroid-induced\x20gastric\x20ulcers\x20or\x20perforation</strong>.</p>\x0a<p><strong>Pyridoxine\x20(Option\x20C):\x20</strong>Pyridoxine\x20(Vitamin\x20B6)\x20is\x20used\x20to\x20prevent\x20<strong>isoniazid-induced\x20neuropathy</strong>,\x20not\x20GI\x20complications.</p>\x0a<p><strong>Folic\x20acid\x20(Option\x20D):\x20</strong>Folic\x20acid\x20is\x20used\x20to\x20manage\x20<strong>folate\x20deficiency</strong>,\x20commonly\x20caused\x20by\x20drugs\x20like\x20methotrexate\x20or\x20in\x20pregnancy,\x20not\x20protective\x20against\x20NSAID-induced\x20GI\x20complications.</p>\x0a<p><strong>Key\x20Takeaway:</strong></p>\x0a<p><strong>H.\x20pylori\x20prophylaxis\x20in\x20PUD:</strong></p>\x0a<ul>\x0a<li><strong>Triple\x20regimen</strong>\x20(clarithromycin-sensitive):</li>\x0a</ul>\x0a<p><strong>CAMP</strong>\x20-\x20Clarithromycin\x20+\x20(Amoxicillin\x20&lt;&lt;\x20Metronidazole)\x20+\x20PPI\x20-\x20for\x202\x20weeks\x20BD</p>\x0a<ul>\x0a<li><strong>Quadruple\x20regimen</strong>\x20(clarithromycin-resistant\x20or\x20failed\x20therapy):</li>\x0a</ul>\x0a<p><strong>TOMB</strong>\x20-\x20Tetracycline\x20+\x20Omeprazole\x20+\x20Metronidazole\x20+\x20Bismuth\x20-\x20for\x2010\x20days\x20to\x206\x20weeks</p>','UKABf','gbLyC','Ivvwb','solution','ixSqM','LBWcZ','<p><span\x20style=\x22font-size:12.0pt;\x22>Nephrolithiasis</span></p>','kCuWe','Not\x20Attempted','appendChild','IWHxF','vpVZc','cbCBp','CLkLx','HSVCA','BPCNI','TRZmm','VptGa','NPdfb','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','dNzPZ','<p><span\x20style=\x22font-size:12.0pt;\x22>Colchicine</span></p>','click','hhneD','ONAPw','apply','DvyFs','attachMedia','YLMef','findIndex','<p><span\x20style=\x22font-size:12.0pt;\x22>Folic\x20acid</span></p>','YuWnK','jXKNb','bind','loadSource','<p><span\x20style=\x22font-size:12.0pt;\x22>a-2,\x20b-4,\x20c-1,\x20d-3</span></p>','bFXkv','<p><span\x20style=\x22font-size:12.0pt;\x22>Icatibant</span></p>','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','PyhLS','RApKN','BKFQb','ymsRE','mcpDw','ygmeE','question_audio','KerFk','style','Grall','explanation_audio_eng','ZXxmc','nOKjU','zZdFJ','Bookmarked','nwyuA','<p><span\x20style=\x22font-size:12.0pt;\x22>Indomethacin</span></p>','xpesJ','avgTimeResult','TIPXY','zlAWg','TsxGw','split','flex','map','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','text','TDQTF','Incorrect','key','border-gray-600','intermediate','LwAbA','xwxXp','kVCwL','wGYxd','ORTFY','accuracyScore','setItem','qNmCI','hidden','floor','YjWvX','fromCharCode','DOtPn','onclick','qqjme','innerHTML','<p><span\x20style=\x22font-size:12.0pt;\x22>Bone\x20marrow\x20suppression\x20and\x20possibly\x20aplastic\x20anemia</span></p>','dYyhT','QDDkj','NEdbO','VSgOS','<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2070-year-old\x20woman\x20presents\x20with\x20nausea\x20and\x20vomiting.\x20She\x20has\x20been\x20taking\x20paracetamol\x20(PCM)\x20for\x20knee\x20pain.\x20On\x20examination,\x20she\x20has\x20scleral\x20icterus\x20and\x20tender\x20hepatomegaly.\x20She\x20also\x20appears\x20confused.<br>Her\x20liver\x20function\x20tests\x20show:<br>ALT:\x20820\x20U/L\x20<br>AST:\x20746\x20U/L<br>\x20ALP:\x20140\x20U/L<br>Which\x20of\x20the\x20following\x20is\x20the\x20most\x20likely\x20underlying\x20mechanism\x20of\x20this\x20patient\x27s\x20liver\x20failure?</span></p>','JxKiB','<p><span\x20style=\x22font-size:12.0pt;\x22>PGF2&alpha;</span></p>','.m3u8','totalQuestionsResult','DT1166667','JfSua','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','DT1166671','WlKdI','customQuizData','FQkRA','vJneY','loQQx','Mark\x20for\x20Review','Dnekm','<p><span\x20style=\x22font-size:12.0pt;\x22>Piroxicam</span></p>','XcUYU','timed_exam','ZyNvt','<p><strong>Explanation:</strong></p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22\x20https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/202403099b44dd9b-2ee2-413f-a3d3-ea573845dbc7.jpg\x22>','getElementById','AfQOn','KQmlQ','selectedAnswer','Kkart','bookmarkBtn','<p><span\x20style=\x22font-size:12.0pt;\x22>Match\x20the\x20following\x20drugs\x20with\x20their\x20respective\x20uses.<br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22\x20https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/20240309405ed74a-6732-40ac-9efd-d76eae9f32e2.jpg\x22></span></p>','PpBJi','border-red-500','WBbfk','vFXLc','DBAlR','add','jrgBo','xQnoL','EICOP','sXZmw','SszVg','wUIoN','KbsUx','nXCBf','<p><span\x20style=\x22font-size:12.0pt;\x22>Gout</span></p>','correct_choice_id','3kpabJu','questionNav','incorrectCount','scoreCircle','DxbxB','FqFvd','oCsvc','<p><span\x20style=\x22font-size:12.0pt;\x22>Sulfasalazine</span></p>','Vgmto','</span><span>','rezPQ','performanceModal','cialv','createElement','No\x20question\x20text\x20available','question_images','<div\x20class=\x22mt-4\x22><img\x20src=\x22','eOKCd','10jLlkou','choices','jcviD','TBVut','pvTbP','AzxfV','ArrowRight','agRXa','DT1166663','ldvqW','<p><strong>Explanation:</strong></p>\x0a<p><strong>Ketorolac</strong>\x20is\x20a\x20potent\x20NSAID\x20with\x20analgesic,\x20anti-inflammatory,\x20and\x20antipyretic\x20properties.\x20It\x20is\x20most\x20widely\x20used\x20for\x20<strong>short-term\x20management\x20</strong>(maximum\x205\x20days)\x20<strong>of\x20moderate\x20to\x20severe\x20pain</strong>,\x20especially\x20in\x20<strong>postoperative\x20settings</strong>,\x20where\x20parenteral\x20administration\x20is\x20preferred.</p>\x0a<ul>\x0a<li>Unlike\x20<strong>aspirin</strong>,\x20ketorolac\x20is\x20available\x20in\x20<strong>injectable\x20formulations\x20(both\x20IM\x20and\x20IV)</strong>,\x20making\x20it\x20highly\x20useful\x20for\x20<strong>patients\x20unable\x20to\x20take\x20oral\x20medications</strong>\x20or\x20those\x20requiring\x20<strong>rapid\x20pain\x20relief</strong>.</li>\x0a<li>This\x20<strong>parenteral\x20availability</strong>\x20is\x20its\x20main\x20advantage\x20over\x20aspirin,\x20which\x20is\x20primarily\x20available\x20in\x20oral\x20and\x20topical\x20forms.</li>\x0a</ul>\x0a<p>However,\x20ketorolac\x20<strong>still\x20carries\x20typical\x20NSAID\x20risks</strong>,\x20including:</p>\x0a<ul>\x0a<li><strong>Prolonged\x20bleeding\x20time</strong>\x20(due\x20to\x20COX-1\x20inhibition\x20and\x20reduced\x20thromboxane\x20A2\x20synthesis).\x20<strong>(Option\x20B\x20ruled\x20out)</strong></li>\x0a<li><strong>Nephrotoxicity</strong>,\x20especially\x20in\x20patients\x20with\x20<strong>preexisting\x20renal\x20impairment.\x20(Option\x20D\x20ruled\x20out)</strong></li>\x0a<li>Hence,\x20it\x20should\x20not\x20be\x20used\x20beyond\x20<strong>5\x20days</strong>,\x20due\x20to\x20increased\x20risk\x20of\x20GI\x20bleeding\x20and\x20nephrotoxicity</li>\x0a</ul>\x0a<p>While\x20ketorolac\x20is\x20sometimes\x20used\x20in\x20combination\x20with\x20opioids\x20for\x20additive\x20analgesic\x20effect,\x20it\x20<strong>does\x20not\x20have\x20a\x20superior\x20safety\x20profile\x20in\x20such\x20combinations</strong>\x20compared\x20to\x20aspirin.<strong>\x20(Option\x20A\x20ruled\x20out)</strong></p>','ENGrz','eBkTo','TZKDn','XpAQB','xRZRV','bottom','<p><span\x20style=\x22font-size:12.0pt;\x22>a-1,\x20b-4,\x20c-2,\x20d-3</span></p>','Jjlca','ikxsY','<p><span\x20style=\x22font-size:12.0pt;\x22>Acetylcholine</span></p>','<p><strong>Explanation:</strong></p>\x0a<p>This\x20patient\x20presents\x20with\x20<strong>acute\x20liver\x20failure</strong>,\x20characterized\x20by\x20<strong>elevated\x20transaminases\x20(ALT\x20and\x20AST\x20&gt;\x20ALP)</strong>,\x20hepatic\x20encephalopathy\x20(confusion),\x20and\x20signs\x20of\x20hepatocellular\x20injury.\x20Her\x20history\x20of\x20<strong>paracetamol\x20(acetaminophen)\x20use</strong>\x20is\x20highly\x20suggestive\x20of\x20<strong>acetaminophen-induced\x20hepatotoxicity</strong>.</p>\x0a<p>Acetaminophen\x20is\x20primarily\x20metabolized\x20in\x20the\x20liver\x20via\x20<strong>glucuronidation\x20and\x20sulfation</strong>.\x20However,\x20a\x20small\x20proportion\x20is\x20oxidized\x20by\x20the\x20<strong>cytochrome\x20P450\x20enzyme\x20CYP2E1</strong>,\x20forming\x20the\x20highly\x20reactive\x20intermediate<strong>\x20N-acetyl-p-benzoquinoneimine\x20(NAPQI)</strong>.</p>\x0a<ul>\x0a<li>Under\x20normal\x20conditions,\x20<strong>NAPQI</strong>\x20is\x20detoxified\x20by\x20<strong>glutathione</strong></li>\x0a<li>In\x20<strong>overdose\x20or\x20chronic\x20high-dose\x20use</strong>,\x20<strong>glutathione\x20stores\x20are\x20depleted</strong>,\x20allowing\x20NAPQI\x20to\x20accumulate.</li>\x0a<li><strong>NAPQI\x20causes\x20oxidative\x20damage</strong>\x20to\x20hepatocytes,\x20leading\x20to\x20<strong>centrilobular\x20necrosis</strong>\x20and\x20<strong>acute\x20liver\x20failure</strong>.</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509059a42fb96-6979-415a-a29f-147a26fdad61.png\x22>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Glucuronide-conjugate\x20formation\x20(Option\x20A):\x20</strong>This\x20is\x20a\x20<strong>normal\x20phase\x20II\x20detoxification\x20pathway</strong>\x20of\x20acetaminophen\x20metabolism.\x20It\x20does\x20<strong>not\x20cause\x20toxicity</strong>\x20and\x20actually\x20helps\x20excrete\x20the\x20drug\x20safely.</p>\x0a<p><strong>Salicylic\x20acid\x20formation\x20(Option\x20B):</strong>.\x20This\x20is\x20part\x20of\x20<strong>aspirin\x20(salicylate)\x20metabolism</strong>,\x20unrelated\x20to\x20acetaminophen\x20toxicity.</p>\x0a<p><strong>N-acetylcysteine\x20formation\x20(Option\x20D):\x20N-acetylcysteine\x20(NAC)</strong>\x20is\x20the\x20<strong>antidote</strong>\x20for\x20acetaminophen\x20poisoning.\x20It\x20acts\x20by\x20<strong>restoring\x20glutathione\x20levels</strong>\x20and\x20detoxifying\x20NAPQI.\x20While\x20critical\x20to\x20treatment,\x20it\x20is\x20<strong>not\x20a\x20mechanism\x20of\x20toxicity</strong>.</p>','kcLfv','<p><strong>Explanation:</strong></p>\x0a<p><strong>Salicylate\x20(aspirin)\x20toxicity</strong>\x20typically\x20presents\x20with\x20a\x20<strong>triad\x20of\x20hyperventilation,\x20metabolic\x20acidosis,\x20and\x20hyperthermia</strong>,\x20especially\x20in\x20<strong>acute\x20overdose\x20in\x20children</strong>.</p>\x0a<ul>\x0a<li><strong>Pathophysiology:</strong>\x20Salicylates\x20uncouple\x20oxidative\x20phosphorylation\x20in\x20mitochondria,\x20leading\x20to\x20<strong>increased\x20heat\x20production</strong>,\x20<strong>lactic\x20acidosis</strong>,\x20and\x20<strong>anion\x20gap\x20metabolic\x20acidosis</strong>.</li>\x0a<li>CNS\x20involvement\x20includes\x20<strong>tinnitus,\x20vertigo</strong>,\x20confusion,\x20and\x20with\x20progression:\x20<strong>seizures,\x20coma</strong>,\x20and\x20potentially\x20death.</li>\x0a<li>Additional\x20findings\x20may\x20include\x20<strong>tachypnea</strong>\x20(due\x20to\x20direct\x20stimulation\x20of\x20the\x20respiratory\x20center),\x20<strong>dehydration</strong>,\x20<strong>electrolyte\x20disturbances</strong>,\x20and\x20<strong>hypoglycemia</strong>.</li>\x0a<li>Children\x20are\x20especially\x20vulnerable\x20due\x20to\x20lower\x20detoxification\x20capacity.</li>\x0a<li>Timely\x20recognition\x20and\x20initiation\x20of\x20treatment\x20with\x20<strong>activated\x20charcoal,\x20correction\x20of\x20acid-base\x20disturbances,\x20</strong>and,\x20if\x20indicated,\x20<strong>hemodialysis</strong>\x20are\x20essential\x20for\x20optimal\x20management.</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Bone\x20marrow\x20suppression\x20and\x20possibly\x20aplastic\x20anemia\x20(Option\x20A):\x20</strong>This\x20is\x20typically\x20seen\x20with\x20<strong>chloramphenicol\x20toxicity</strong>,\x20not\x20aspirin.</p>\x0a<p><strong>Fever,\x20hepatic\x20dysfunction,\x20and\x20encephalopathy\x20(Option\x20B):\x20</strong>These\x20findings\x20are\x20more\x20consistent\x20with\x20<strong>Reye\x27s\x20syndrome</strong>,\x20which\x20occurs\x20when\x20aspirin\x20is\x20given\x20to\x20children\x20during\x20or\x20after\x20<strong>viral\x20infections</strong>.\x20However,\x20this\x20is\x20<strong>not\x20the\x20acute\x20overdose\x20presentation</strong>\x20of\x20salicylate\x20toxicity.</p>\x0a<p><strong>Rapid,\x20fulminant\x20hepatic\x20failure\x20(Option\x20D):\x20</strong>This\x20is\x20characteristic\x20of\x20<strong>acetaminophen\x20(paracetamol)\x20overdose</strong>,\x20which\x20causes\x20centrilobular\x20hepatic\x20necrosis,\x20not\x20salicylate\x20toxicity.</p>','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','DT1166674','oRUFc','prevBtn','Bookmark','FZnFo','Factual','<p><span\x20style=\x22font-size:12.0pt;\x22>Salicylic\x20acid\x20formation</span></p>','questions','location','XcsLp','fZsYA','kauEy','NfcLZ','Autacoids\x20Part\x202','toLowerCase','qOfLr','stats','GVkzH','<p><span\x20style=\x22font-size:12.0pt;\x22>Interstitial\x20nephritis</span></p>','aoeAp','div','incomplete','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','incorrect','correctAnswers','remove','WCmHU','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','OrSvL','review-question\x20','kFLdD','crelh','fOwlb','navBtn_','<p><span\x20style=\x22font-size:12.0pt;\x22>Alpha-1\x20receptor</span></p>','FXrsa','HdSRg','CMCnK','<p><span\x20style=\x22font-size:12.0pt;\x22>Does\x20not\x20prolong\x20the\x20bleeding\x20time</span></p>','selected','fqhub','timerContainer','yxcLI','kYcwt','qZjDf','CsImF','YMQUR','LUSHW','YKowQ','solutionText','<p><span\x20style=\x22font-size:12.0pt;\x22>Over\x20the\x20next\x207\x20months,\x20the\x20patient\x20had\x20two\x20more\x20attacks\x20of\x20acute\x20gout.\x20Her\x20serum\x20uric\x20acid\x20levels\x20were\x20elevated.\x20The\x20decision\x20was\x20made\x20to\x20initiate\x20chronic\x20drug\x20therapy\x20to\x20prevent\x20further\x20attacks.\x20Which\x20of\x20the\x20following\x20drugs\x20can\x20be\x20used\x20to\x20decrease\x20the\x20production\x20of\x20uric\x20acid?</span></p>','JtsqG','dzqfB','mvPiT','<p><span\x20style=\x22font-size:12.0pt;\x22>Hyperthermia,\x20metabolic\x20acidosis,\x20and\x20coma</span></p>','HZJtI','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.'];_0x5dea=function(){return _0x41acd8;};return _0x5dea();}let questionsData=[{'id':0x1,'choices':[{'id':0x1,'text':_0x2bb813(0x22d)},{'id':0x2,'text':_0x2bb813(0x36b)},{'id':0x3,'text':_0x2bb813(0x26f)},{'id':0x4,'text':_0x2bb813(0x2f7)}],'text':_0x2bb813(0x2c3),'unique_key':'DT1166642','question_audio':null,'question_video':null,'map_id':0x11cd32,'difficulty_level':_0x2bb813(0x292),'subjects_id':[0x1],'solution':_0x2bb813(0x2bc),'correct_choice_id':0x4,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x2,'choices':[{'id':0xb,'text':_0x2bb813(0x3b4)},{'id':0xc,'text':_0x2bb813(0x2aa)},{'id':0xd,'text':_0x2bb813(0x322)},{'id':0xe,'text':_0x2bb813(0x1ea)}],'text':_0x2bb813(0x381),'unique_key':_0x2bb813(0x3fd),'question_audio':null,'question_video':null,'map_id':0x11cd34,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x2bb813(0x363),'correct_choice_id':0xc,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2bb813(0x2f6),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x3,'choices':[{'id':0x15,'text':_0x2bb813(0x2fa)},{'id':0x16,'text':_0x2bb813(0x20e)},{'id':0x17,'text':_0x2bb813(0x40a)},{'id':0x18,'text':_0x2bb813(0x3fc)}],'text':_0x2bb813(0x1fd),'unique_key':_0x2bb813(0x38c),'question_audio':null,'question_video':null,'map_id':0x11cd39,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x2bb813(0x211),'correct_choice_id':0x15,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2bb813(0x2f6),'tags':[_0x2bb813(0x304)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x4,'choices':[{'id':0x1f,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Glucuronide-conjugate\x20formation</span></p>'},{'id':0x20,'text':_0x2bb813(0x305)},{'id':0x21,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>N-acetyl-p-benzoquinoneimine\x20formation</span></p>'},{'id':0x22,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>N-acetylcysteine\x20formation</span></p>'}],'text':_0x2bb813(0x2a8),'unique_key':_0x2bb813(0x3e7),'question_audio':null,'question_video':null,'map_id':0x11cd3d,'difficulty_level':_0x2bb813(0x292),'subjects_id':[0x1],'solution':_0x2bb813(0x2fb),'correct_choice_id':0x21,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x5,'choices':[{'id':0x29,'text':_0x2bb813(0x3ee)},{'id':0x2a,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Omeprazole</span></p>'},{'id':0x2b,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Pyridoxine</span></p>'},{'id':0x2c,'text':_0x2bb813(0x26a)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2042-year-old\x20woman\x20presents\x20with\x20abdominal\x20pain,\x20nausea,\x20and\x20vomiting.\x20She\x20is\x20currently\x20on\x20prednisone\x20and\x20naproxen.\x20On\x20examination,\x20she\x20has\x20a\x20rigid\x20abdomen\x20with\x20rebound\x20tenderness\x20and\x20hypoactive\x20bowel\x20sounds.\x20Labs\x20show\x20a\x20leukocyte\x20count\x20of\x2013,300/mm3\x20and\x20an\x20ESR\x20of\x2070\x20mm/h.\x20Chest\x20X-ray\x20is\x20taken\x20and\x20is\x20shown\x20below.\x20Treatment\x20with\x20which\x20of\x20the\x20following\x20could\x20have\x20prevented\x20this\x20complication?<br><img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22\x20https://d3d535v34tlady.cloudfront.net/NEETPGMCQ/2024030956a783e1-9c78-4cf7-8497-303f0313c8f1.jpg\x22></span></p>','unique_key':'DT1166657','question_audio':null,'question_video':null,'map_id':0x11cd41,'difficulty_level':_0x2bb813(0x292),'subjects_id':[0x1],'solution':_0x2bb813(0x24b),'correct_choice_id':0x2a,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2bb813(0x304)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x6,'choices':[{'id':0x33,'text':_0x2bb813(0x283)},{'id':0x34,'text':_0x2bb813(0x3ec)},{'id':0x35,'text':_0x2bb813(0x45d)},{'id':0x36,'text':_0x2bb813(0x358)}],'text':_0x2bb813(0x44f),'unique_key':_0x2bb813(0x22c),'question_audio':null,'question_video':null,'map_id':0x11cd44,'difficulty_level':_0x2bb813(0x292),'subjects_id':[0x1],'solution':_0x2bb813(0x240),'correct_choice_id':0x33,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2bb813(0x2f6),'tags':[_0x2bb813(0x304)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x7,'choices':[{'id':0x3d,'text':_0x2bb813(0x271)},{'id':0x3e,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Danazol</span></p>'},{'id':0x3f,'text':_0x2bb813(0x42f)},{'id':0x40,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Lanadelumab</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2014-year-old\x20boy\x20is\x20brought\x20in\x20with\x20progressive\x20shortness\x20of\x20breath,\x20difficulty\x20speaking,\x20and\x20diffuse,\x20colicky\x20abdominal\x20pain\x20for\x20the\x20past\x203\x20hours.\x20He\x20had\x20undergone\x20a\x20tooth\x20extraction\x20yesterday.\x20His\x20father\x20has\x20a\x20history\x20of\x20repeated\x20hospitalizations\x20for\x20orofacial\x20swelling.\x20Administration\x20of\x20a\x20drug\x20targeting\x20which\x20of\x20the\x20following\x20is\x20the\x20most\x20appropriate\x20treatment\x20for\x20this\x20patient?</span></p>','unique_key':_0x2bb813(0x1f5),'question_audio':null,'question_video':null,'map_id':0x11cd46,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x2bb813(0x359),'correct_choice_id':0x3d,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2bb813(0x2f6),'tags':[_0x2bb813(0x304)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x8,'choices':[{'id':0x47,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Chlorthalidone</span></p>'},{'id':0x48,'text':_0x2bb813(0x403)},{'id':0x49,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Losartan</span></p>'},{'id':0x4a,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Nifedipine</span></p>'}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2032-year-old\x20woman\x20presents\x20with\x20facial\x20swelling\x20and\x20difficulty\x20swallowing.\x20She\x20was\x20recently\x20diagnosed\x20with\x20hypertension\x20and\x20started\x20on\x20an\x20antihypertensive\x20drug.\x20Which\x20of\x20the\x20following\x20is\x20the\x20most\x20likely\x20cause\x20of\x20this\x20patient\x27s\x20symptoms?</span></p>','unique_key':_0x2bb813(0x2ee),'question_audio':null,'question_video':null,'map_id':0x11cd47,'difficulty_level':_0x2bb813(0x292),'subjects_id':[0x1],'solution':_0x2bb813(0x42c),'correct_choice_id':0x48,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2bb813(0x2f6),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x9,'choices':[{'id':0x51,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Withdraw\x20ibuprofen</span></p>'},{'id':0x52,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Start\x20ceftriaxone</span></p>'},{'id':0x53,'text':_0x2bb813(0x1e4)},{'id':0x54,'text':_0x2bb813(0x202)}],'text':_0x2bb813(0x1d4),'unique_key':_0x2bb813(0x2ad),'question_audio':null,'question_video':null,'map_id':0x11cd4b,'difficulty_level':_0x2bb813(0x292),'subjects_id':[0x1],'solution':_0x2bb813(0x450),'correct_choice_id':0x51,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xa,'choices':[{'id':0x5b,'text':_0x2bb813(0x408)},{'id':0x5c,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Nimesulide</span></p>'},{'id':0x5d,'text':_0x2bb813(0x2b8)},{'id':0x5e,'text':_0x2bb813(0x380)}],'text':_0x2bb813(0x38b),'unique_key':_0x2bb813(0x2b0),'question_audio':null,'question_video':null,'map_id':0x11cd4f,'difficulty_level':_0x2bb813(0x292),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p><strong>Piroxicam</strong>\x20is\x20a\x20non-selective\x20NSAID\x20belonging\x20to\x20the\x20oxicam\x20class.\x20One\x20of\x20its\x20unique\x20pharmacokinetic\x20properties\x20is\x20that\x20it\x20undergoes\x20<strong>extensive\x20enterohepatic\x20circulation</strong>,\x20which\x20significantly\x20<strong>prolongs\x20its\x20half-life\x20(~45-50\x20hours)</strong>\x20and\x20allows\x20for\x20<strong>once-daily\x20dosing</strong>.\x20This\x20also\x20contributes\x20to\x20its\x20<strong>long\x20duration\x20of\x20action</strong>,\x20making\x20it\x20effective\x20in\x20the\x20<strong>management\x20of\x20chronic\x20inflammatory\x20conditions</strong>\x20like\x20osteoarthritis\x20and\x20rheumatoid\x20arthritis.</p>\x0a<ul>\x0a<li><strong>Enterohepatic\x20metabolism</strong>\x20refers\x20to\x20the\x20process\x20where\x20a\x20drug\x20is\x20excreted\x20into\x20bile\x20after\x20hepatic\x20metabolism,\x20enters\x20the\x20intestine,\x20and\x20is\x20then\x20<strong>reabsorbed</strong>\x20into\x20systemic\x20circulation,\x20extending\x20the\x20drug\x27s\x20activity.</li>\x0a</ul>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250905f84afadf-442e-40a9-9089-25cd408f1734.png\x22>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Diclofenac\x20(Option\x20A):</strong>\x20While\x20diclofenac\x20undergoes\x20<strong>hepatic\x20metabolism</strong>,\x20it\x20shows\x20<strong>limited\x20enterohepatic\x20recirculation</strong>\x20and\x20is\x20mostly\x20excreted\x20via\x20urine.\x20Its\x20shorter\x20half-life\x20(~1-2\x20hours)\x20makes\x20it\x20unsuitable\x20for\x20long-acting\x20effects.</p>\x0a<p><strong>Nimesulide\x20(Option\x20B):</strong>\x20Nimesulide\x20is\x20metabolized\x20in\x20the\x20liver\x20and\x20excreted\x20mainly\x20in\x20the\x20urine.\x20It\x20does\x20<strong>not\x20exhibit\x20significant\x20enterohepatic\x20circulation</strong>.\x20It\x20is\x20also\x20not\x20recommended\x20for\x20long-term\x20use\x20due\x20to\x20<strong>hepatic\x20toxicity</strong>\x20concerns.</p>\x0a<p><strong>Ketorolac\x20(Option\x20D):</strong>\x20Ketorolac\x20is\x20a\x20short-acting\x20NSAID,\x20mainly\x20used\x20for\x20<strong>acute\x20pain</strong>,\x20especially\x20post-operative.\x20It\x20undergoes\x20hepatic\x20metabolism\x20and\x20<strong>does\x20not\x20undergo\x20significant\x20enterohepatic\x20recycling</strong>.\x20Its\x20duration\x20of\x20action\x20is\x20short\x20(half-life\x20~4-6\x20hours).</p>','correct_choice_id':0x5d,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2bb813(0x2f6),'tags':[_0x2bb813(0x304)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xb,'choices':[{'id':0x65,'text':_0x2bb813(0x408)},{'id':0x66,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Nimesulide</span></p>'},{'id':0x67,'text':_0x2bb813(0x2b8)},{'id':0x68,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Celecoxib</span></p>'}],'text':_0x2bb813(0x3e2),'unique_key':_0x2bb813(0x2ff),'question_audio':null,'question_video':null,'map_id':0x11cd52,'difficulty_level':_0x2bb813(0x292),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p>This\x20patient\x20presents\x20with\x20classic\x20features\x20of\x20<strong>knee\x20osteoarthritis\x20(OA)</strong>,\x20both\x20clinically\x20and\x20radiologically:</p>\x0a<ul>\x0a<li><strong>Joint\x20space\x20narrowing</strong>,\x20<strong>subchondral\x20sclerosis</strong>,\x20and\x20<strong>osteophyte\x20formation</strong>\x20on\x20X-ray\x20are\x20hallmark\x20features\x20of\x20OA.</li>\x0a<li>NSAIDs\x20are\x20the\x20mainstay\x20for\x20symptomatic\x20relief\x20in\x20OA.\x20However,\x20the\x20patient\x27s\x20<strong>history\x20of\x20peptic\x20ulcer\x20disease\x20(PUD)</strong>\x20makes\x20<strong>non-selective\x20NSAIDs</strong>\x20risky\x20due\x20to\x20their\x20<strong>COX-1\x20inhibition</strong>,\x20which\x20impairs\x20gastric\x20mucosal\x20protection.</li>\x0a</ul>\x0a<p><strong>Celecoxib</strong>\x20is\x20a\x20<strong>selective\x20COX-2\x20inhibitor</strong>,\x20offering\x20<strong>anti-inflammatory\x20and\x20analgesic\x20effects</strong>\x20similar\x20to\x20traditional\x20NSAIDs\x20but\x20with\x20<strong>less\x20risk\x20of\x20GI\x20toxicity</strong>\x20since\x20it\x20<strong>spares\x20COX-1</strong>.</p>\x0a<p>This\x20makes\x20<strong>celecoxib\x20the\x20most\x20appropriate\x20agent</strong>\x20in\x20patients\x20with\x20GI\x20comorbidities\x20like\x20PUD.</p>\x0a<img\x20class=\x22w-100\x22\x20style=\x22height:auto;\x20display:block;\x20vertical-align:middle;\x20border:0;\x20\x22src=\x22https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202509057296fd37-5086-4b31-90d0-db361bcebdad.png\x22>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Diclofenac\x20(Option\x20A):</strong>\x20A\x20<strong>non-selective\x20NSAID</strong>\x20that\x20inhibits\x20both\x20COX-1\x20and\x20COX-2.\x20While\x20effective\x20for\x20pain,\x20it\x20carries\x20a\x20<strong>high\x20risk\x20of\x20gastric\x20irritation\x20and\x20ulceration</strong>,\x20which\x20is\x20undesirable\x20in\x20patients\x20with\x20<strong>peptic\x20ulcer\x20disease</strong>.</p>\x0a<p><strong>Nimesulide\x20(Option\x20B):</strong>\x20Although\x20it\x20has\x20some\x20<strong>COX-2\x20preference</strong>,\x20it\x20is\x20not\x20a\x20fully\x20selective\x20COX-2\x20inhibitor.\x20It\x20still\x20poses\x20<strong>GI\x20and\x20hepatic\x20risks</strong>,\x20and\x20is\x20not\x20a\x20safer\x20alternative\x20in\x20a\x20patient\x20with\x20<strong>PUD</strong>.</p>\x0a<p><strong>Piroxicam\x20(Option\x20C):</strong>\x20A\x20long-acting\x20<strong>non-selective\x20NSAID</strong>\x20associated\x20with\x20<strong>high\x20GI\x20toxicity</strong>,\x20especially\x20in\x20elderly\x20patients\x20and\x20those\x20with\x20a\x20prior\x20history\x20of\x20ulcers.\x20<strong>Not\x20recommended</strong>\x20in\x20this\x20patient\x20population.</p>','correct_choice_id':0x68,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2bb813(0x2f6),'tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xc,'choices':[{'id':0x6f,'text':_0x2bb813(0x34b)},{'id':0x70,'text':_0x2bb813(0x252)},{'id':0x71,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Papillary\x20necrosis</span></p>'},{'id':0x72,'text':_0x2bb813(0x311)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>A\x2036-year-old\x20woman\x20with\x20chronic\x20tension\x20headaches\x20on\x20aspirin\x20presents\x20with\x20several\x20episodes\x20of\x20bilateral\x20flank\x20pain\x20and\x20reddish\x20urine\x20over\x20the\x20past\x20month.\x20Her\x20temperature\x20is\x2099&deg;F,\x20and\x20blood\x20pressure\x20is\x20160/90\x20mm\x20Hg.\x20Physical\x20examination\x20reveals\x20bilateral\x20costovertebral\x20angle\x20tenderness.\x20Laboratory\x20findings\x20show:<br>Hemoglobin:\x2010.2\x20g/dL<br>Serum\x20creatinine:\x202\x20mg/dL<br>Urinalysis:<br>1.\x20Protein:\x20+<br>2.\x20RBCs:\x20>12/hpf<br>3.\x20WBCs:\x202/hpf<br>Which\x20of\x20the\x20following\x20is\x20the\x20most\x20likely\x20underlying\x20cause\x20of\x20this\x20patient\x27s\x20hematuria?</span></p>','unique_key':_0x2bb813(0x218),'question_audio':null,'question_video':null,'map_id':0x11cd59,'difficulty_level':_0x2bb813(0x292),'subjects_id':[0x1],'solution':_0x2bb813(0x35e),'correct_choice_id':0x71,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2bb813(0x304)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xd,'choices':[{'id':0x79,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Can\x20be\x20combined\x20more\x20safely\x20with\x20an\x20opioid\x20such\x20as\x20codeine</span></p>'},{'id':0x7a,'text':_0x2bb813(0x326)},{'id':0x7b,'text':_0x2bb813(0x3e6)},{'id':0x7c,'text':_0x2bb813(0x1d1)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>The\x20main\x20advantage\x20of\x20ketorolac\x20over\x20aspirin\x20is\x20that\x20ketorolac:</span></p>','unique_key':_0x2bb813(0x3e1),'question_audio':null,'question_video':null,'map_id':0x11cd5b,'difficulty_level':_0x2bb813(0x292),'subjects_id':[0x1],'solution':_0x2bb813(0x2f0),'correct_choice_id':0x7b,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2bb813(0x2f6),'tags':[_0x2bb813(0x304)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xe,'choices':[{'id':0x83,'text':_0x2bb813(0x358)},{'id':0x84,'text':_0x2bb813(0x261)},{'id':0x85,'text':_0x2bb813(0x433)},{'id':0x86,'text':_0x2bb813(0x45d)}],'text':_0x2bb813(0x33c),'unique_key':_0x2bb813(0x41d),'question_audio':null,'question_video':null,'map_id':0x11cd5f,'difficulty_level':_0x2bb813(0x292),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p>Methotrexate\x20is\x20a\x20<strong>weak\x20acid</strong>\x20that\x20undergoes\x20<strong>renal\x20elimination</strong>,\x20largely\x20via\x20<strong>active\x20tubular\x20secretion</strong>\x20in\x20the\x20<strong>proximal\x20tubule</strong>.</p>\x0a<p><strong>Probenecid</strong>,\x20a\x20uricosuric\x20agent,\x20<strong>inhibits\x20organic\x20anion\x20transporters\x20(OATs)</strong>,\x20especially\x20in\x20the\x20proximal\x20renal\x20tubule,\x20thereby\x20interfering\x20with\x20the\x20<strong>tubular\x20secretion</strong>\x20of\x20weak\x20acids\x20such\x20as\x20<strong>methotrexate</strong>\x20and\x20<strong>penicillin</strong>.\x20By\x20competitively\x20inhibiting\x20this\x20transporter,\x20<strong>probenecid\x20reduces\x20methotrexate\x20clearance</strong>,\x20causing\x20<strong>increased\x20serum\x20concentrations</strong>,\x20and\x20hence\x20may\x20increase\x20the\x20risk\x20of\x20<strong>methotrexate\x20toxicity</strong>.</p>\x0a<p><strong>Probenecid:</strong></p>\x0a<ul>\x0a<li><strong>Mechanism\x20of\x20action:</strong>\x0a<ul>\x0a<li>Inhibits\x20<strong>URAT1</strong>\x20transporter\x20in\x20the\x20proximal\x20tubule\x20&rarr;\x20&darr;\x20uric\x20acid\x20reabsorption\x20&rarr;\x20&uarr;\x20uric\x20acid\x20excretion\x20(uricosuric\x20effect)</li>\x0a<li><strong>Inhibits\x20tubular\x20secretion\x20of\x20weak\x20acids</strong>\x20(e.g.,\x20methotrexate,\x20penicillin)\x20&rarr;\x20&uarr;\x20serum\x20concentrations\x20of\x20such\x20drugs</li>\x0a</ul>\x0a</li>\x0a<li><strong>Uses:</strong>\x0a<ul>\x0a<li>Treatment\x20of\x20<strong>chronic\x20gout</strong>\x20(not\x20used\x20in\x20acute\x20attacks)</li>\x0a<li>Historically\x20used\x20to\x20<strong>prolong\x20the\x20action\x20of\x20penicillin</strong>\x20by\x20decreasing\x20its\x20renal\x20clearance</li>\x0a</ul>\x0a</li>\x0a<li><strong>Contraindications:</strong>\x0a<ul>\x0a<li><strong>Renal\x20stones\x20(urate\x20nephrolithiasis)</strong></li>\x0a<li><strong>Renal\x20insufficiency</strong></li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Allopurinol\x20(Option\x20A):</strong>\x20Xanthine\x20oxidase\x20inhibitor,\x20used\x20to\x20lower\x20uric\x20acid\x20production.\x20It\x20<strong>does\x20not\x20affect\x20renal\x20tubular\x20secretion\x20of\x20methotrexate</strong>.\x20However,\x20it\x20may\x20increase\x20toxicity\x20of\x20drugs\x20like\x206-mercaptopurine.</p>\x0a<p><strong>Colchicine\x20(Option\x20B):\x20</strong>Used\x20for\x20<strong>acute\x20gout</strong>,\x20acts\x20via\x20inhibition\x20of\x20microtubule\x20polymerization.\x20It\x20<strong>does\x20not\x20interfere\x20with\x20methotrexate\x20excretion</strong>.</p>\x0a<p><strong>Hydroxychloroquine\x20(Option\x20C):\x20</strong>An\x20antimalarial\x20and\x20immunomodulator\x20used\x20in\x20<strong>SLE\x20and\x20RA</strong>;\x20<strong>no\x20effect\x20on\x20methotrexate\x20excretion</strong>.</p>','correct_choice_id':0x86,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2bb813(0x304)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0xf,'choices':[{'id':0x8d,'text':_0x2bb813(0x45a)},{'id':0x8e,'text':_0x2bb813(0x2d2)},{'id':0x8f,'text':_0x2bb813(0x427)},{'id':0x90,'text':_0x2bb813(0x39f)}],'text':_0x2bb813(0x3f5),'unique_key':_0x2bb813(0x418),'question_audio':null,'question_video':null,'map_id':0x11cd61,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x2bb813(0x3dc),'correct_choice_id':0x8f,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2bb813(0x2f6),'tags':[_0x2bb813(0x304)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x10,'choices':[{'id':0x97,'text':_0x2bb813(0x358)},{'id':0x98,'text':_0x2bb813(0x3ec)},{'id':0x99,'text':_0x2bb813(0x433)},{'id':0x9a,'text':_0x2bb813(0x45d)}],'text':_0x2bb813(0x332),'unique_key':'DT1166690','question_audio':null,'question_video':null,'map_id':0x11cd62,'difficulty_level':_0x2bb813(0x292),'subjects_id':[0x1],'solution':'<p><strong>Explanation:</strong></p>\x0a<p>The\x20goal\x20of\x20chronic\x20therapy\x20in\x20gout\x20is\x20to\x20reduce\x20<strong>serum\x20uric\x20acid\x20levels</strong>\x20and\x20prevent\x20further\x20acute\x20attacks.</p>\x0a<p><strong>Allopurinol</strong>\x20is\x20a\x20<strong>xanthine\x20oxidase\x20inhibitor</strong>,\x20which\x20blocks\x20the\x20conversion\x20of\x20hypoxanthine\x20and\x20xanthine\x20into\x20<strong>uric\x20acid</strong>,\x20thus\x20directly\x20<strong>reducing\x20uric\x20acid\x20production</strong>.\x20It\x20is\x20the\x20drug\x20of\x20choice\x20for\x20<strong>chronic\x20management</strong>\x20in\x20patients\x20with\x20recurrent\x20gout\x20or\x20complications\x20like\x20tophi\x20or\x20uric\x20acid\x20nephropathy.</p>\x0a<ul>\x0a<li><strong>Mechanism\x20of\x20Action:</strong>\x20Inhibits\x20<strong>xanthine\x20oxidase</strong>\x20&rarr;\x20&darr;\x20uric\x20acid\x20synthesis</li>\x0a<li><strong>Key\x20adverse\x20effects:</strong>\x0a<ul>\x0a<li><strong>Rash</strong>,\x20including\x20rare\x20but\x20severe\x20<strong>Stevens-Johnson\x20Syndrome\x20(SJS)/Toxic\x20Epidermal\x20Necrolysis\x20(TEN)</strong></li>\x0a<li><strong>Allopurinol\x20Hypersensitivity\x20Syndrome\x20(AHS)</strong>:\x20life-threatening\x20with\x20rash,\x20renal\x20and\x20hepatic\x20dysfunction</li>\x0a</ul>\x0a</li>\x0a<li><strong>Drug\x20interactions:</strong>\x20&uarr;\x20toxicity\x20of\x20<strong>azathioprine</strong>\x20and\x20<strong>6-mercaptopurine</strong>\x20&rarr;\x20dose\x20reduction\x20required</li>\x0a<li><strong>Allopurinol\x20should\x20never\x20be\x20initiated\x20during\x20an\x20acute\x20gout\x20flare</strong>,\x20as\x20<strong>it\x20may\x20transiently\x20worsen\x20the\x20attack</strong>\x20by\x20altering\x20uric\x20acid\x20levels\x20and\x20triggering\x20further\x20crystal\x20mobilization.\x20Initiation\x20should\x20only\x20occur\x20once\x20the\x20acute\x20episode\x20has\x20fully\x20resolved,\x20and\x20typically\x20with\x20concurrent\x20anti-inflammatory\x20prophylaxis\x20(e.g.,\x20colchicine\x20or\x20NSAIDs).</li>\x0a</ul>\x0a<p><strong>Explanation\x20of\x20Other\x20Options:</strong></p>\x0a<p><strong>Aspirin\x20(Option\x20B):</strong>\x20<strong>Low-dose\x20aspirin</strong>\x20inhibits\x20renal\x20uric\x20acid\x20excretion,\x20thereby\x20<strong>raising\x20serum\x20uric\x20acid\x20levels</strong>,\x20<strong>contraindicated\x20in\x20gout</strong>.</p>\x0a<p><strong>Hydroxychloroquine\x20(Option\x20C):</strong>\x20This\x20is\x20an\x20<strong>immunomodulatory\x20drug</strong>\x20used\x20in\x20<strong>rheumatoid\x20arthritis</strong>\x20and\x20<strong>SLE</strong>.\x20It\x20has\x20<strong>no\x20role\x20in\x20uric\x20acid\x20metabolism</strong>.</p>\x0a<p><strong>Probenecid\x20(Option\x20D):</strong>\x20Probenecid\x20is\x20a\x20<strong>uricosuric\x20agent</strong>,\x20which\x20<strong>increases\x20excretion</strong>\x20of\x20uric\x20acid\x20via\x20renal\x20tubular\x20inhibition\x20of\x20reabsorption.\x20It\x20does\x20<strong>not\x20reduce\x20production</strong>,\x20and\x20is\x20contraindicated\x20in\x20renal\x20dysfunction\x20or\x20uric\x20acid\x20nephrolithiasis.</p>','correct_choice_id':0x97,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':_0x2bb813(0x2f6),'tags':[_0x2bb813(0x304)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x11,'choices':[{'id':0xa1,'text':_0x2bb813(0x2a3)},{'id':0xa2,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Fever,\x20hepatic\x20dysfunction,\x20and\x20encephalopathy</span></p>'},{'id':0xa3,'text':_0x2bb813(0x336)},{'id':0xa4,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Rapid,\x20fulminant\x20hepatic\x20failure</span></p>'}],'text':_0x2bb813(0x45e),'unique_key':'DT1166691','question_audio':null,'question_video':null,'map_id':0x11cd63,'difficulty_level':_0x2bb813(0x292),'subjects_id':[0x1],'solution':_0x2bb813(0x2fd),'correct_choice_id':0xa3,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2bb813(0x304)],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x12,'choices':[{'id':0xab,'text':_0x2bb813(0x43e)},{'id':0xac,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Etanercept</span></p>'},{'id':0xad,'text':_0x2bb813(0x405)},{'id':0xae,'text':_0x2bb813(0x2db)}],'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Which\x20of\x20the\x20following\x20is\x20a\x20parenterally\x20administered\x20DMARD\x20whose\x20mechanism\x20of\x20anti-inflammatory\x20action\x20is\x20antagonism\x20of\x20tumor\x20necrosis\x20factor?</span></p>','unique_key':'DT1166692','question_audio':null,'question_video':null,'map_id':0x11cd64,'difficulty_level':_0x2bb813(0x292),'subjects_id':[0x1],'solution':_0x2bb813(0x1f8),'correct_choice_id':0xac,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':['Factual'],'explanation_video':null,'question_images':[],'explanation_images':[]},{'id':0x13,'choices':[{'id':0xb5,'text':_0x2bb813(0x3b9)},{'id':0xb6,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Rash</span></p>'},{'id':0xb7,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Severe\x20diarrhea</span></p>'},{'id':0xb8,'text':'<p><span\x20style=\x22font-size:12.0pt;\x22>Sudden\x20gastrointestinal\x20bleeding</span></p>'}],'text':_0x2bb813(0x425),'unique_key':'DT1166696','question_audio':null,'question_video':null,'map_id':0x11cd68,'difficulty_level':'intermediate','subjects_id':[0x1],'solution':_0x2bb813(0x419),'correct_choice_id':0xb7,'solution_audio':null,'solution_video':null,'audio_explanation_heading':null,'video_explanation_heading':null,'solution_media_position':'bottom','tags':[_0x2bb813(0x304)],'explanation_video':null,'question_images':[],'explanation_images':[]}],quizName=_0x2bb813(0x30c);const quizFilename=_0x2bb813(0x3e0);let hierarchy=[_0x2bb813(0x404),_0x2bb813(0x206),'Pharmacology'];if(window['location'][_0x2bb813(0x3c3)][_0x2bb813(0x361)]('custom_quiz.html')){const customData=JSON[_0x2bb813(0x33a)](localStorage[_0x2bb813(0x416)](_0x2bb813(0x2b2)));if(customData){const vGiHjK='4|1|3|5|2|0'[_0x2bb813(0x289)]('|');let EszyEO=0x0;while(!![]){switch(vGiHjK[EszyEO++]){case'0':document[_0x2bb813(0x2bd)](_0x2bb813(0x43b))[_0x2bb813(0x371)]=hierarchy[_0x2bb813(0x394)]('\x20>\x20');continue;case'1':quizName=customData['name'];continue;case'2':document[_0x2bb813(0x2bd)]('totalQuestions')[_0x2bb813(0x371)]=questionsData[_0x2bb813(0x3f7)];continue;case'3':hierarchy=customData[_0x2bb813(0x406)];continue;case'4':questionsData=customData[_0x2bb813(0x306)];continue;case'5':document['title']=quizName+_0x2bb813(0x3c7);continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x2bb813(0x249),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x2bb813(0x34f)](),quizStartTime=Date['now'](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x2bb813(0x3f7)])[_0x2bb813(0x213)](null)[_0x2bb813(0x28b)](()=>({'status':_0x2bb813(0x460),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData[_0x2bb813(0x3f7)]};function saveProgress(){const _0x38eaf8=_0x2bb813,_0x2832bc={'viupJ':'userHistory','crelh':_0x38eaf8(0x314)};if(isQuizCompleted)return;const _0x54e779=JSON[_0x38eaf8(0x33a)](localStorage[_0x38eaf8(0x416)](_0x2832bc['viupJ']))||{};_0x54e779[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x2832bc[_0x38eaf8(0x31f)],'lastSeen':new Date()[_0x38eaf8(0x3a3)]()},localStorage[_0x38eaf8(0x299)](_0x2832bc[_0x38eaf8(0x1c9)],JSON[_0x38eaf8(0x3ba)](_0x54e779));}function loadProgress(){const _0x16c9e3=_0x2bb813,_0x3b2cf2={'TsxGw':'userHistory','TISdz':_0x16c9e3(0x383),'XHkpO':_0x16c9e3(0x347)},_0x15991f=JSON[_0x16c9e3(0x33a)](localStorage['getItem'](_0x3b2cf2[_0x16c9e3(0x288)]))||{},_0x1d9084=_0x15991f[quizFilename];if(_0x1d9084){const _0x5276f7=_0x3b2cf2['TISdz'][_0x16c9e3(0x289)]('|');let _0x22d46f=0x0;while(!![]){switch(_0x5276f7[_0x22d46f++]){case'0':questionStates=_0x1d9084[_0x16c9e3(0x1ce)];continue;case'1':currentMode=_0x1d9084[_0x16c9e3(0x1e3)];continue;case'2':return!![];case'3':currentQuestionIndex=_0x1d9084['currentQuestionIndex'];continue;case'4':console[_0x16c9e3(0x35a)](_0x3b2cf2[_0x16c9e3(0x447)]);continue;case'5':stats=_0x1d9084[_0x16c9e3(0x30f)];continue;}break;}}return![];}function clearProgress(){const _0xe8cf6a=_0x2bb813,_0x2e071c={'JOsmY':'userHistory','wYrlQ':function(_0x4baa34,_0x113475){return _0x4baa34===_0x113475;},'aZCOB':'dzqfB'},_0x1dc466=JSON[_0xe8cf6a(0x33a)](localStorage[_0xe8cf6a(0x416)](_0x2e071c[_0xe8cf6a(0x38e)]))||{};_0x1dc466[quizFilename]&&(_0x2e071c['wYrlQ'](_0xe8cf6a(0x334),_0x2e071c[_0xe8cf6a(0x1c0)])?(delete _0x1dc466[quizFilename],localStorage[_0xe8cf6a(0x299)](_0x2e071c[_0xe8cf6a(0x38e)],JSON[_0xe8cf6a(0x3ba)](_0x1dc466)),console[_0xe8cf6a(0x35a)](_0xe8cf6a(0x22b))):_0x2caf43[_0xe8cf6a(0x21f)]=_0x40e329);}function markQuizAsCompleted(){const _0x31ea4d=_0x2bb813,_0x226a5e={'TsPqP':_0x31ea4d(0x1e1)},_0x13b5c7=JSON[_0x31ea4d(0x33a)](localStorage['getItem'](_0x226a5e[_0x31ea4d(0x342)]))||{},_0x57a5c9=questionsData[_0x31ea4d(0x3f7)],_0xf9d2e5=stats['correctAnswers']||0x0;_0x13b5c7[quizFilename]={'score':_0xf9d2e5,'total':_0x57a5c9,'status':_0x31ea4d(0x37c),'completedOn':new Date()[_0x31ea4d(0x3a3)]()},localStorage[_0x31ea4d(0x299)](_0x226a5e[_0x31ea4d(0x342)],JSON[_0x31ea4d(0x3ba)](_0x13b5c7));}const urlParams=new URLSearchParams(window[_0x2bb813(0x307)][_0x2bb813(0x1c5)]),startAt=parseInt(urlParams[_0x2bb813(0x46d)](_0x2bb813(0x368))),resume=urlParams['get']('resume')===_0x2bb813(0x357);function goBack(){const _0x337511=_0x2bb813,_0x49a835={'jvDti':function(_0x4697d4){return _0x4697d4();},'RTgCF':_0x337511(0x233)};if(!isQuizCompleted)_0x49a835[_0x337511(0x410)](saveProgress);window[_0x337511(0x307)]['href']=document[_0x337511(0x22a)]||_0x49a835[_0x337511(0x463)];}function selectMode(_0x1eca4d){const _0x13ffff=_0x2bb813,_0x4db1ed={'qNmCI':_0x13ffff(0x1e7)};currentMode=_0x1eca4d,document['getElementById'](_0x13ffff(0x451))[_0x13ffff(0x27b)][_0x13ffff(0x244)]=_0x4db1ed[_0x13ffff(0x29a)],initializeQuiz();}function initializeQuiz(){const _0x56ecb8=_0x2bb813,_0x3e5e4b={'wPxao':'bookmarkBtn','INzyK':function(_0x4ab4af,_0x55220c){return _0x4ab4af===_0x55220c;},'AxpUH':_0x56ecb8(0x1f2),'FjitT':_0x56ecb8(0x3d8),'YkgXJ':_0x56ecb8(0x3cb),'ooqXo':_0x56ecb8(0x1e7),'OAOSX':'submitSection','hwJLz':_0x56ecb8(0x28a),'TBVut':'timed_study','RSmXy':_0x56ecb8(0x2ba),'IWHxF':function(_0x5783c1,_0x37dda){return _0x5783c1===_0x37dda;},'ndDws':_0x56ecb8(0x3ab),'vFXLc':function(_0x36dc52,_0x36eaad){return _0x36dc52(_0x36eaad);},'UDRxw':function(_0x3abeb3,_0x59b3b0){return _0x3abeb3<_0x59b3b0;},'ENGrz':function(_0x3d13e6){return _0x3d13e6();},'XcsLp':function(_0x204d69){return _0x204d69();}};quizStartTime=Date[_0x56ecb8(0x34f)]();const _0x49aebd=document[_0x56ecb8(0x2bd)](_0x3e5e4b[_0x56ecb8(0x223)]),_0x1438e9=document[_0x56ecb8(0x2bd)](_0x56ecb8(0x3cd)),_0x364a86=document[_0x56ecb8(0x2bd)](_0x56ecb8(0x21b)),_0x27aa7d=_0x3e5e4b[_0x56ecb8(0x399)](currentMode,_0x3e5e4b[_0x56ecb8(0x374)])||_0x3e5e4b[_0x56ecb8(0x399)](currentMode,_0x56ecb8(0x2ba));document[_0x56ecb8(0x2bd)](_0x3e5e4b[_0x56ecb8(0x370)])['style']['display']=_0x27aa7d?_0x56ecb8(0x1e7):_0x3e5e4b[_0x56ecb8(0x1ed)],document[_0x56ecb8(0x2bd)](_0x56ecb8(0x3f9))[_0x56ecb8(0x27b)][_0x56ecb8(0x244)]=_0x27aa7d?_0x3e5e4b[_0x56ecb8(0x1d9)]:_0x56ecb8(0x3cb),document[_0x56ecb8(0x2bd)](_0x56ecb8(0x3c0))['style'][_0x56ecb8(0x244)]=_0x27aa7d?_0x3e5e4b[_0x56ecb8(0x1ed)]:_0x3e5e4b[_0x56ecb8(0x1d9)],document['getElementById'](_0x3e5e4b[_0x56ecb8(0x3e8)])[_0x56ecb8(0x27b)][_0x56ecb8(0x244)]=_0x27aa7d?_0x3e5e4b[_0x56ecb8(0x1ed)]:_0x3e5e4b['ooqXo'],_0x49aebd[_0x56ecb8(0x27b)][_0x56ecb8(0x244)]=_0x27aa7d?_0x56ecb8(0x1e7):_0x3e5e4b[_0x56ecb8(0x1ca)],_0x1438e9[_0x56ecb8(0x27b)][_0x56ecb8(0x244)]=_0x27aa7d?_0x3e5e4b[_0x56ecb8(0x1ca)]:_0x3e5e4b[_0x56ecb8(0x1d9)],_0x364a86[_0x56ecb8(0x27b)]['display']=_0x27aa7d?_0x3e5e4b['hwJLz']:'none';if(_0x3e5e4b[_0x56ecb8(0x399)](currentMode,_0x3e5e4b[_0x56ecb8(0x2e9)])||currentMode===_0x3e5e4b[_0x56ecb8(0x467)]){if(_0x3e5e4b[_0x56ecb8(0x256)]('KFJDP',_0x3e5e4b[_0x56ecb8(0x46e)])){_0xc063e9['totalAttempted']++,_0x3cff3c[_0x56ecb8(0x1dc)]--;if(_0x481c78)_0x3d408c['correctAnswers']++;else _0x47f424[_0x56ecb8(0x3de)]++;}else document[_0x56ecb8(0x2bd)](_0x56ecb8(0x329))[_0x56ecb8(0x1d5)][_0x56ecb8(0x318)](_0x56ecb8(0x29b));}!_0x3e5e4b[_0x56ecb8(0x2c7)](isNaN,startAt)&&startAt>=0x0&&_0x3e5e4b[_0x56ecb8(0x366)](startAt,questionsData['length'])&&(currentQuestionIndex=startAt),_0x3e5e4b[_0x56ecb8(0x2f1)](loadBookmarkedQuestions),_0x3e5e4b[_0x56ecb8(0x2f1)](generateQuestionNav),updateStats(),_0x3e5e4b[_0x56ecb8(0x308)](displayQuestion);}function generateQuestionNav(){const _0x5f33ef=_0x2bb813,_0x1cc73b={'uWIaW':_0x5f33ef(0x34e),'NstYL':function(_0x87580b,_0x40bae6){return _0x87580b+_0x40bae6;},'Ivvwb':'w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','PNMcX':function(_0x3c29d4,_0x3183f6){return _0x3c29d4<_0x3183f6;},'AfQOn':_0x5f33ef(0x369),'KbsUx':function(_0x8e6a39,_0x32d29c){return _0x8e6a39+_0x32d29c;},'loQQx':function(_0x1ac332){return _0x1ac332();}},_0x4c9517=document['getElementById'](_0x5f33ef(0x2d5));_0x4c9517[_0x5f33ef(0x2a2)]='';for(let _0x5a86f8=0x0;_0x1cc73b[_0x5f33ef(0x3f6)](_0x5a86f8,questionsData['length']);_0x5a86f8++){if(_0x1cc73b[_0x5f33ef(0x2be)]===_0x1cc73b[_0x5f33ef(0x2be)]){const _0x4bbdf0=document[_0x5f33ef(0x2e1)](_0x1cc73b[_0x5f33ef(0x430)]);_0x4bbdf0['textContent']=_0x1cc73b[_0x5f33ef(0x2d0)](_0x5a86f8,0x1),_0x4bbdf0[_0x5f33ef(0x215)]=_0x1cc73b[_0x5f33ef(0x24e)],_0x4bbdf0['onclick']=()=>jumpToQuestion(_0x5a86f8),_0x4bbdf0['id']=_0x5f33ef(0x321)+_0x5a86f8,_0x4c9517[_0x5f33ef(0x255)](_0x4bbdf0);}else{const _0x1a4e63=_0x5d7f08[_0x5f33ef(0x2e1)](_0x1cc73b[_0x5f33ef(0x430)]);_0x1a4e63['textContent']=_0x1cc73b[_0x5f33ef(0x445)](_0x45069d,0x1),_0x1a4e63[_0x5f33ef(0x215)]=_0x1cc73b[_0x5f33ef(0x24e)],_0x1a4e63[_0x5f33ef(0x2a0)]=()=>_0x3874a1(_0x368a63),_0x1a4e63['id']=_0x5f33ef(0x321)+_0x5bc7fb,_0x18d30c['appendChild'](_0x1a4e63);}}_0x1cc73b[_0x5f33ef(0x2b5)](updateQuestionNav);}function updateQuestionNav(){const _0x3295e8=_0x2bb813,_0x1c6788={'bFXkv':_0x3295e8(0x233),'QMiOZ':function(_0x120e9c,_0x4e962b){return _0x120e9c<_0x4e962b;},'oTubB':function(_0x3c4c34,_0x14bfdf){return _0x3c4c34===_0x14bfdf;},'ihbEd':_0x3295e8(0x401),'mfxKU':_0x3295e8(0x3c8),'LEEAo':_0x3295e8(0x227),'eAnvx':_0x3295e8(0x40f),'XhchA':function(_0x54c394,_0x58fb76){return _0x54c394===_0x58fb76;},'DYlbX':_0x3295e8(0x249),'anmNB':_0x3295e8(0x236),'mWiCe':_0x3295e8(0x34a),'qfxqo':'nav-btn-correct','SMcfd':function(_0x2b7f03,_0x1baf7d){return _0x2b7f03===_0x1baf7d;},'jSSdk':_0x3295e8(0x316),'Uaqpw':_0x3295e8(0x3d3),'GYtKb':_0x3295e8(0x1be),'tGzxs':function(_0x3a0885,_0x134116){return _0x3a0885!==_0x134116;},'evGdj':_0x3295e8(0x1c3)};for(let _0x27fdc3=0x0;_0x1c6788[_0x3295e8(0x355)](_0x27fdc3,questionsData[_0x3295e8(0x3f7)]);_0x27fdc3++){const _0x360ef5=document[_0x3295e8(0x2bd)]('navBtn_'+_0x27fdc3),_0x1c8054=questionStates[_0x27fdc3];let _0x247302='';if(_0x27fdc3===currentQuestionIndex){if(_0x1c6788[_0x3295e8(0x222)](_0x1c6788[_0x3295e8(0x455)],_0x1c6788[_0x3295e8(0x41b)])){if(!_0x48697e)_0x608397();_0x3926ba['location'][_0x3295e8(0x409)]=_0x29c958[_0x3295e8(0x22a)]||_0x1c6788[_0x3295e8(0x270)];}else _0x247302=_0x3295e8(0x214);}else{if(_0x1c8054[_0x3295e8(0x1db)])_0x247302=_0x1c6788[_0x3295e8(0x37a)];else{if(_0x1c8054[_0x3295e8(0x44b)])_0x247302=_0x1c6788[_0x3295e8(0x3d6)];else{if(_0x1c6788[_0x3295e8(0x226)](currentMode,_0x1c6788[_0x3295e8(0x43c)])||_0x1c6788['oTubB'](currentMode,_0x1c6788[_0x3295e8(0x40e)])){if(_0x1c6788[_0x3295e8(0x226)](_0x1c8054[_0x3295e8(0x458)],_0x1c6788[_0x3295e8(0x3f2)]))_0x247302=_0x1c6788[_0x3295e8(0x225)];else{if(_0x1c6788[_0x3295e8(0x3b3)](_0x1c8054[_0x3295e8(0x458)],_0x1c6788[_0x3295e8(0x3c6)]))_0x247302=_0x1c6788[_0x3295e8(0x3df)];else _0x247302=_0x1c6788['GYtKb'];}}else{if(_0x1c6788['tGzxs'](_0x1c8054[_0x3295e8(0x2c0)],null))_0x247302=_0x1c6788[_0x3295e8(0x40b)];else _0x247302=_0x3295e8(0x1be);}}}}_0x360ef5[_0x3295e8(0x215)]=_0x3295e8(0x1df)+_0x247302;}}function jumpToQuestion(_0x3f7fd4){const _0x39c204=_0x2bb813,_0x40d0cb={'jrgBo':function(_0x1c5637,_0x4bd82e){return _0x1c5637>=_0x4bd82e;},'lujbk':function(_0x31f383,_0x736816){return _0x31f383<_0x736816;},'hwjNR':function(_0x4d48b2,_0x45b70b){return _0x4d48b2-_0x45b70b;},'ysPGt':function(_0x2aad61){return _0x2aad61();},'BPCNI':function(_0x55be4d){return _0x55be4d();}};_0x40d0cb[_0x39c204(0x2ca)](_0x3f7fd4,0x0)&&_0x40d0cb[_0x39c204(0x1ff)](_0x3f7fd4,questionsData['length'])&&(questionStartTime&&(questionStates[currentQuestionIndex][_0x39c204(0x392)]+=_0x40d0cb['hwjNR'](Date[_0x39c204(0x34f)](),questionStartTime)),currentQuestionIndex=_0x3f7fd4,_0x40d0cb[_0x39c204(0x1bf)](displayQuestion),_0x40d0cb[_0x39c204(0x25b)](saveProgress));}function updateStats(){const _0x4a65a1=_0x2bb813,_0x3ad6ff={'oRUFc':function(_0x126de1,_0x2a82c4){return _0x126de1===_0x2a82c4;},'broux':_0x4a65a1(0x460),'BKFQb':_0x4a65a1(0x316),'sLQiW':function(_0x30d506){return _0x30d506();},'PhDal':function(_0x15437b,_0x1e0c15){return _0x15437b(_0x1e0c15);},'fqhub':'timed_study','nXCBf':_0x4a65a1(0x3d4),'zXcCx':_0x4a65a1(0x341),'LBWcZ':function(_0x58ef2f,_0x26e7ee){return _0x58ef2f>_0x26e7ee;},'OcyDq':function(_0x5e30c8,_0x2dd936){return _0x5e30c8*_0x2dd936;},'wlaZt':function(_0x445049,_0x18d00d){return _0x445049/_0x18d00d;},'QGFRR':'accuracy','PqwvS':function(_0x123357,_0x345eba){return _0x123357+_0x345eba;},'fKcNW':function(_0xbdd0be,_0x1b3f69){return _0xbdd0be/_0x1b3f69;},'EUMvc':function(_0x108f30,_0x13ba22){return _0x108f30/_0x13ba22;},'DNBfE':function(_0x5108b7,_0x33f1bc){return _0x5108b7%_0x33f1bc;},'nHPWt':_0x4a65a1(0x392),'WCmHU':function(_0x40ed52,_0x365d2b){return _0x40ed52+_0x365d2b;},'NuJmm':function(_0x51b888,_0x412be4){return _0x51b888+_0x412be4;}};if(_0x3ad6ff[_0x4a65a1(0x300)](currentMode,_0x4a65a1(0x249))||currentMode===_0x3ad6ff[_0x4a65a1(0x328)]){if(_0x4a65a1(0x335)===_0x4a65a1(0x1bd)){const _0x50e73d=_0x46f39d[_0x83ea12],_0x17f930=_0x50e73d[_0x4a65a1(0x2d3)];if(_0x5f5858===null)return;const _0x599239=_0x50e73d[_0x4a65a1(0x2e7)][_0x46ac30],_0x39e558=_0x3ad6ff[_0x4a65a1(0x300)](_0x599239['id'],_0x17f930);if(_0x3ad6ff[_0x4a65a1(0x300)](_0x45246b[_0x5676c6]['status'],_0x3ad6ff[_0x4a65a1(0x1e6)])){_0x2a98ee['totalAttempted']++,_0x25c02b['notAttempted']--;if(_0x39e558)_0x425173[_0x4a65a1(0x317)]++;else _0xbbf150[_0x4a65a1(0x3de)]++;}_0x276496[_0x56cdea][_0x4a65a1(0x458)]=_0x39e558?_0x4a65a1(0x34a):_0x3ad6ff[_0x4a65a1(0x275)],_0x3ad6ff[_0x4a65a1(0x37d)](_0x45c43a),_0x3ad6ff['PhDal'](_0x341bb7,_0x39e558),_0x5a4f26();}else{document[_0x4a65a1(0x2bd)](_0x3ad6ff[_0x4a65a1(0x2d1)])[_0x4a65a1(0x371)]=stats[_0x4a65a1(0x317)],document[_0x4a65a1(0x2bd)](_0x4a65a1(0x2d6))['textContent']=stats[_0x4a65a1(0x3de)],document[_0x4a65a1(0x2bd)](_0x3ad6ff['zXcCx'])[_0x4a65a1(0x371)]=stats[_0x4a65a1(0x341)];const _0x2acd6c=_0x3ad6ff[_0x4a65a1(0x251)](stats[_0x4a65a1(0x341)],0x0)?Math['round'](_0x3ad6ff['OcyDq'](_0x3ad6ff['wlaZt'](stats['correctAnswers'],stats[_0x4a65a1(0x341)]),0x64)):0x0;document[_0x4a65a1(0x2bd)](_0x3ad6ff[_0x4a65a1(0x1bc)])['textContent']=_0x3ad6ff['PqwvS'](_0x2acd6c,'%'),stats[_0x4a65a1(0x407)]=questionStates[_0x4a65a1(0x462)]((_0x62edc1,_0x1dd8db)=>_0x62edc1+_0x1dd8db['timeSpent'],0x0);const _0x5e57a2=Math['floor'](_0x3ad6ff[_0x4a65a1(0x200)](stats['totalTime'],0x3e8)),_0x5d9c91=Math['floor'](_0x3ad6ff[_0x4a65a1(0x365)](_0x5e57a2,0x3c)),_0xadaaef=_0x3ad6ff[_0x4a65a1(0x3f3)](_0x5e57a2,0x3c);document[_0x4a65a1(0x2bd)](_0x3ad6ff['nHPWt'])[_0x4a65a1(0x371)]=_0x3ad6ff[_0x4a65a1(0x319)](_0x3ad6ff[_0x4a65a1(0x461)](_0x5d9c91,':'),_0xadaaef[_0x4a65a1(0x3bd)]()['padStart'](0x2,'0'));}}}function setupVideo(_0x38bc2b,_0x5d5a62){const _0x1680e8=_0x2bb813,_0x4fa94c={'Scxtr':_0x1680e8(0x3ad)};if(Hls[_0x1680e8(0x449)]()){const _0x409f2a=new Hls();_0x409f2a[_0x1680e8(0x26e)](_0x5d5a62),_0x409f2a[_0x1680e8(0x267)](_0x38bc2b);}else _0x38bc2b[_0x1680e8(0x43a)](_0x4fa94c[_0x1680e8(0x239)])&&(_0x38bc2b[_0x1680e8(0x21f)]=_0x5d5a62);}function displayQuestion(){const _0x5815b3=_0x2bb813,_0x5571b4={'dNzPZ':function(_0x59b7be,_0x2c66ef,_0x4acca4){return _0x59b7be(_0x2c66ef,_0x4acca4);},'wGYxd':function(_0x49c9d6,_0x58304d){return _0x49c9d6+_0x58304d;},'HgCfM':function(_0x596b3f,_0x391c76){return _0x596b3f===_0x391c76;},'ywXnw':'selected','zlAWg':'Option\x20','srTQe':function(_0xd287da,_0x5d1190){return _0xd287da(_0x5d1190);},'JnImU':_0x5815b3(0x35b),'zymAK':function(_0x50ca51,_0x10f407){return _0x50ca51===_0x10f407;},'zyGSr':_0x5815b3(0x3a2),'YKowQ':'CoLdg','DOtPn':_0x5815b3(0x389),'DxbxB':function(_0x305c73,_0x5f0189){return _0x305c73!==_0x5f0189;},'ymsRE':'cnAWS','lzlLc':_0x5815b3(0x274),'VuvTt':_0x5815b3(0x42e),'kPFJv':'No\x20questions\x20available\x20for\x20this\x20quiz.','edTrW':function(_0xfda7fd,_0x257db4){return _0xfda7fd*_0x257db4;},'ZdUip':function(_0x1b5dda,_0x561bbb){return _0x1b5dda/_0x561bbb;},'uaNqQ':'progressBar','NfcLZ':function(_0x2db0f6,_0x564be9){return _0x2db0f6+_0x564be9;},'qZael':_0x5815b3(0x3fb),'DSgQQ':_0x5815b3(0x301),'JZnUX':_0x5815b3(0x1cf),'ygmeE':_0x5815b3(0x29b),'VptGa':_0x5815b3(0x3a9),'bxxBm':'OgRQb','GleDe':_0x5815b3(0x44c),'yVfxq':_0x5815b3(0x375),'PyhLS':_0x5815b3(0x3a1),'xFyDw':_0x5815b3(0x262),'SLgDn':function(_0x33186d){return _0x33186d();},'JMwha':_0x5815b3(0x2ba)};if(!questionsData||questionsData[_0x5815b3(0x3f7)]===0x0){document['getElementById'](_0x5571b4[_0x5815b3(0x344)])[_0x5815b3(0x2a2)]=_0x5571b4[_0x5815b3(0x1c8)];return;};const _0x5e5ca0=questionsData[currentQuestionIndex];questionStartTime=Date[_0x5815b3(0x34f)](),selectedOption=questionStates[currentQuestionIndex]['selectedAnswer'];const _0x4d3afc=_0x5571b4['edTrW'](_0x5571b4[_0x5815b3(0x457)](currentQuestionIndex+0x1,questionsData[_0x5815b3(0x3f7)]),0x64);document['getElementById'](_0x5571b4['uaNqQ'])['style'][_0x5815b3(0x20d)]=_0x5571b4[_0x5815b3(0x30b)](_0x4d3afc,'%'),document[_0x5815b3(0x2bd)](_0x5571b4[_0x5815b3(0x362)])[_0x5815b3(0x371)]=currentQuestionIndex+0x1,updateQuestionNav(),document[_0x5815b3(0x2bd)](_0x5571b4['DSgQQ'])[_0x5815b3(0x41a)]=_0x5571b4[_0x5815b3(0x3f8)](currentQuestionIndex,0x0),document['getElementById'](_0x5571b4['JZnUX'])[_0x5815b3(0x1d5)][_0x5815b3(0x2c9)](_0x5571b4[_0x5815b3(0x278)]),document[_0x5815b3(0x2bd)](_0x5571b4[_0x5815b3(0x344)])['innerHTML']=_0x5e5ca0['text']||_0x5815b3(0x2e2);let _0x126924='';if(_0x5e5ca0[_0x5815b3(0x279)])_0x126924+=_0x5815b3(0x36e)+_0x5e5ca0['question_audio']+_0x5815b3(0x219);if(_0x5e5ca0[_0x5815b3(0x346)])_0x126924+=_0x5815b3(0x3a8)+_0x5e5ca0[_0x5815b3(0x346)]+_0x5815b3(0x2fe);_0x5e5ca0[_0x5815b3(0x2e3)]&&(_0x5571b4[_0x5815b3(0x25d)]!==_0x5571b4[_0x5815b3(0x209)]?_0x5e5ca0[_0x5815b3(0x2e3)][_0x5815b3(0x248)](_0x17b975=>{const _0x1644c1=_0x5815b3;if(_0x17b975)_0x126924+=_0x1644c1(0x3a5)+_0x17b975+_0x1644c1(0x373);}):_0x5571b4[_0x5815b3(0x260)](_0x1fe189,_0x1e5680,_0x24091e));document[_0x5815b3(0x2bd)](_0x5571b4[_0x5815b3(0x3b2)])[_0x5815b3(0x2a2)]=_0x126924;const _0x29013a=document['getElementById'](_0x5571b4['yVfxq']);_0x29013a[_0x5815b3(0x2a2)]='',_0x29013a[_0x5815b3(0x1d5)][_0x5815b3(0x318)](_0x5571b4[_0x5815b3(0x273)]),_0x5e5ca0[_0x5815b3(0x2e7)]&&Array['isArray'](_0x5e5ca0[_0x5815b3(0x2e7)])&&(_0x5e5ca0['choices'][_0x5815b3(0x248)]((_0x25c6b2,_0x4c52a5)=>{const _0x42a8c6=_0x5815b3,_0x56e414=String['fromCharCode'](_0x5571b4[_0x42a8c6(0x296)](0x41,_0x4c52a5)),_0x1a794c=_0x5571b4['HgCfM'](selectedOption,_0x4c52a5),_0x2bb2fa=document['createElement'](_0x42a8c6(0x313));_0x2bb2fa['innerHTML']=_0x42a8c6(0x2af)+(_0x1a794c?_0x5571b4['ywXnw']:'')+_0x42a8c6(0x378)+_0x4c52a5+_0x42a8c6(0x38f)+_0x56e414+_0x42a8c6(0x393)+(_0x25c6b2[_0x42a8c6(0x28d)]||_0x5571b4[_0x42a8c6(0x296)](_0x5571b4[_0x42a8c6(0x287)],_0x5571b4[_0x42a8c6(0x296)](_0x4c52a5,0x1)))+_0x42a8c6(0x28c),_0x29013a[_0x42a8c6(0x255)](_0x2bb2fa);}),_0x29013a[_0x5815b3(0x1cb)](_0x5571b4[_0x5815b3(0x1f7)],function(_0x3cc055){const _0x117c6a=_0x5815b3,_0x1349fb={'AzxfV':function(_0x4c2459,_0x255f3c){return _0x4c2459-_0x255f3c;}};if(_0x5571b4['zymAK'](_0x5571b4[_0x117c6a(0x434)],_0x5571b4[_0x117c6a(0x330)]))_0x5571b4['srTQe'](_0x31059e,_0x5571b4[_0x117c6a(0x400)])&&_0x2ff2eb();else{const _0x5a8393=_0x3cc055[_0x117c6a(0x35d)][_0x117c6a(0x245)](_0x5571b4[_0x117c6a(0x29f)]);if(_0x5a8393){if(_0x5571b4[_0x117c6a(0x2d8)](_0x5571b4[_0x117c6a(0x276)],_0x5571b4[_0x117c6a(0x340)])){const _0x4dea02=parseInt(_0x5a8393[_0x117c6a(0x385)](_0x117c6a(0x23f)));_0x5571b4['srTQe'](selectOption,_0x4dea02);}else _0x21cc3d[_0x561ee4][_0x117c6a(0x392)]+=_0x1349fb[_0x117c6a(0x2eb)](_0x4f2754['now'](),_0x44409a);}}})),_0x5571b4[_0x5815b3(0x348)](updateBookmarkButton),_0x5571b4[_0x5815b3(0x348)](updateMarkReviewButton),(currentMode==='timed_study'||_0x5571b4[_0x5815b3(0x3f8)](currentMode,_0x5571b4[_0x5815b3(0x428)]))&&!isQuizCompleted&&startTimer();}function selectOption(_0x82bdee){const _0x2f71fa=_0x2bb813,_0x1db2b2={'wYJtP':function(_0x1c639f,_0x476d02){return _0x1c639f===_0x476d02;},'lnMPb':_0x2f71fa(0x34a),'TZKDn':_0x2f71fa(0x316),'JvZir':_0x2f71fa(0x258),'FfZgz':function(_0x308f1a){return _0x308f1a();},'JLBbG':_0x2f71fa(0x375),'LgMFk':_0x2f71fa(0x3a1),'DBAlR':function(_0x41a2a1,_0x39482d){return _0x41a2a1!==_0x39482d;},'KQmlQ':_0x2f71fa(0x3eb),'CeiBw':'.option-button','anMil':_0x2f71fa(0x236),'uLaKN':function(_0x3313ca){return _0x3313ca();},'agDUL':function(_0x244e54,_0x2c4e24){return _0x244e54===_0x2c4e24;},'FkmjH':'TAwGF','Zkgjo':_0x2f71fa(0x2b3),'JtsqG':'not_attempted','xWhmK':function(_0x251fce,_0xbe16aa){return _0x251fce!==_0xbe16aa;},'tGVKl':_0x2f71fa(0x201),'igNVH':_0x2f71fa(0x40d),'rPcsp':function(_0x5415e7){return _0x5415e7();}},_0x5e3b0c=document['getElementById'](_0x1db2b2['JLBbG']);if(_0x5e3b0c[_0x2f71fa(0x1d5)]['contains'](_0x1db2b2[_0x2f71fa(0x44a)]))return;questionStartTime&&(_0x1db2b2[_0x2f71fa(0x2c8)]('aWCwj',_0x1db2b2[_0x2f71fa(0x2bf)])?_0x5ef8b2[_0x2f71fa(0x2a2)]+=_0x2f71fa(0x21c)+_0x457103[_0x2f71fa(0x27d)]+_0x2f71fa(0x219):(questionStates[currentQuestionIndex][_0x2f71fa(0x392)]+=Date[_0x2f71fa(0x34f)]()-questionStartTime,questionStartTime=Date['now']())),selectedOption=_0x82bdee,questionStates[currentQuestionIndex]['selectedAnswer']=_0x82bdee,document[_0x2f71fa(0x3b0)](_0x1db2b2[_0x2f71fa(0x228)])[_0x2f71fa(0x248)]((_0xacb7ef,_0x365bcd)=>{const _0x4f9e53=_0x2f71fa;_0x4f9e53(0x2cd)===_0x1db2b2[_0x4f9e53(0x1f4)]?_0x1db2b2[_0x4f9e53(0x386)](_0x5066cc[_0x4f9e53(0x2e7)][_0x407407['selectedAnswer']]['id'],_0x3725fc[_0x4f9e53(0x2d3)])?(_0x27b838++,_0x3fe649[_0x4f9e53(0x458)]=_0x1db2b2['lnMPb']):(_0x1a6b37++,_0x453803['status']=_0x1db2b2[_0x4f9e53(0x2f3)]):_0xacb7ef[_0x4f9e53(0x1d5)][_0x4f9e53(0x440)](_0x4f9e53(0x327),_0x1db2b2[_0x4f9e53(0x386)](_0x365bcd,_0x82bdee));}),currentMode===_0x2f71fa(0x249)||currentMode===_0x1db2b2[_0x2f71fa(0x3bf)]?_0x1db2b2[_0x2f71fa(0x3d0)](processAnswer):_0x1db2b2[_0x2f71fa(0x1b9)](_0x1db2b2[_0x2f71fa(0x36f)],_0x1db2b2[_0x2f71fa(0x41f)])?_0x1db2b2[_0x2f71fa(0x38a)](_0x47c7ea):(_0x1db2b2[_0x2f71fa(0x386)](questionStates[currentQuestionIndex][_0x2f71fa(0x458)],_0x1db2b2[_0x2f71fa(0x333)])&&(_0x1db2b2[_0x2f71fa(0x354)](_0x1db2b2[_0x2f71fa(0x46f)],_0x1db2b2[_0x2f71fa(0x3af)])?(questionStates[currentQuestionIndex][_0x2f71fa(0x458)]=_0x2f71fa(0x3a1),stats[_0x2f71fa(0x341)]++,stats[_0x2f71fa(0x1dc)]--):(_0x536030++,_0x1db2b2['FfZgz'](_0x4280db),_0x1db2b2[_0x2f71fa(0x38a)](_0x2ef9fd))),_0x1db2b2['FfZgz'](updateQuestionNav)),_0x1db2b2[_0x2f71fa(0x3da)](saveProgress);}function processAnswer(){const _0x55cf3b=_0x2bb813,_0x4ed550={'YLMef':function(_0x43435f,_0xd0e2ce){return _0x43435f===_0xd0e2ce;},'XpAQB':_0x55cf3b(0x460),'NEdbO':_0x55cf3b(0x34a),'jKdKg':_0x55cf3b(0x316)},_0x58e54c=questionsData[currentQuestionIndex],_0x25a82f=_0x58e54c[_0x55cf3b(0x2d3)];if(selectedOption===null)return;const _0x8b2c6e=_0x58e54c[_0x55cf3b(0x2e7)][selectedOption],_0xf9ef48=_0x4ed550[_0x55cf3b(0x268)](_0x8b2c6e['id'],_0x25a82f);if(questionStates[currentQuestionIndex][_0x55cf3b(0x458)]===_0x4ed550[_0x55cf3b(0x2f4)]){stats[_0x55cf3b(0x341)]++,stats['notAttempted']--;if(_0xf9ef48)stats['correctAnswers']++;else stats['incorrectAnswers']++;}questionStates[currentQuestionIndex][_0x55cf3b(0x458)]=_0xf9ef48?_0x4ed550[_0x55cf3b(0x2a6)]:_0x4ed550['jKdKg'],updateStats(),showInlineFeedback(_0xf9ef48),updateQuestionNav();}function showInlineFeedback(_0x48503b){const _0x51fb35=_0x2bb813,_0x511493={'noowd':function(_0x4a1e74,_0x16a9e4){return _0x4a1e74===_0x16a9e4;},'ikxsY':_0x51fb35(0x34a),'KnOrW':function(_0x517438,_0x302120){return _0x517438===_0x302120;},'NqkSd':'incorrect','kOfuV':function(_0x176258,_0x3d70b7){return _0x176258!==_0x3d70b7;},'Mvznz':_0x51fb35(0x249),'fPEmj':_0x51fb35(0x375),'rwcxA':_0x51fb35(0x3a1),'ldvqW':function(_0x3ad2af){return _0x3ad2af();}};if(_0x511493['kOfuV'](currentMode,_0x511493[_0x51fb35(0x1d6)])&&currentMode!=='timed_study')return;const _0x1fad1c=document[_0x51fb35(0x2bd)](_0x511493[_0x51fb35(0x3fa)]),_0x28eb79=_0x1fad1c[_0x51fb35(0x3b0)](_0x51fb35(0x389)),_0x40ed93=questionsData[currentQuestionIndex],_0x1cc1f6=_0x40ed93[_0x51fb35(0x2d3)];let _0x5f0ff5=_0x40ed93[_0x51fb35(0x2e7)][_0x51fb35(0x269)](_0x3c6a01=>_0x3c6a01['id']===_0x1cc1f6);_0x1fad1c[_0x51fb35(0x1d5)][_0x51fb35(0x2c9)](_0x511493['rwcxA']),_0x28eb79[_0x51fb35(0x248)]((_0x276e6d,_0x32dd20)=>{const _0x1b6356=_0x51fb35;_0x276e6d[_0x1b6356(0x1d5)][_0x1b6356(0x318)]('selected');if(_0x511493[_0x1b6356(0x439)](_0x32dd20,_0x5f0ff5))_0x276e6d['classList'][_0x1b6356(0x2c9)](_0x511493[_0x1b6356(0x2f9)]);else{if(_0x511493[_0x1b6356(0x343)](_0x32dd20,selectedOption)&&!_0x48503b)_0x276e6d[_0x1b6356(0x1d5)][_0x1b6356(0x2c9)](_0x511493[_0x1b6356(0x3b7)]);}}),_0x511493[_0x51fb35(0x2ef)](showSolution);}function showSolution(){const _0x7fd54f=_0x2bb813,_0x49bf3a={'NYOxd':function(_0x548433,_0x4300ce){return _0x548433(_0x4300ce);},'MBCAJ':_0x7fd54f(0x338),'CmPmd':'customQuizData','FCqAH':function(_0x171086){return _0x171086();},'yFJVR':'.option-button','aoeAp':function(_0x1b28ba,_0x11e595){return _0x1b28ba(_0x11e595);},'fGZIN':'data-option-index','cdOPK':function(_0x27b06f,_0x530d38){return _0x27b06f(_0x530d38);},'zjxBo':function(_0x30039a,_0x4fe25d){return _0x30039a+_0x4fe25d;},'HSVCA':function(_0x2360c5,_0x461a8a){return _0x2360c5===_0x461a8a;},'YjWvX':_0x7fd54f(0x313),'WhIcy':_0x7fd54f(0x22e),'zugbM':'click','WBbfk':_0x7fd54f(0x3cd),'EAOGy':_0x7fd54f(0x37b),'zZdFJ':_0x7fd54f(0x23b),'RfCVr':'Marked','HZJtI':_0x7fd54f(0x2b6),'zfwvg':_0x7fd54f(0x1c3),'vJneY':_0x7fd54f(0x1be),'WGpGc':'BENka','FtwZD':'UiQYy','QfekR':function(_0x42c7ad,_0x2b4b2a){return _0x42c7ad!==_0x2b4b2a;},'ZIWtb':_0x7fd54f(0x236),'UAPyC':_0x7fd54f(0x331),'EAjbu':_0x7fd54f(0x1ec),'Zyrbz':_0x7fd54f(0x415),'fCMWP':function(_0x2a99c7,_0x172f69){return _0x2a99c7!==_0x172f69;},'QUvXC':_0x7fd54f(0x3c1),'ONAPw':_0x7fd54f(0x29b),'vpVZc':'.m3u8','CLkLx':function(_0x341be8,_0x22b7f2,_0x180688){return _0x341be8(_0x22b7f2,_0x180688);},'mcpDw':function(_0x4e465c,_0x1c8b7a){return _0x4e465c===_0x1c8b7a;},'uxPXL':_0x7fd54f(0x2a5),'smXLx':_0x7fd54f(0x41c),'qZjDf':_0x7fd54f(0x31e),'DmRiH':_0x7fd54f(0x203),'jXKNb':_0x7fd54f(0x1cf)};if(_0x49bf3a[_0x7fd54f(0x459)](currentMode,_0x7fd54f(0x249))&&_0x49bf3a[_0x7fd54f(0x459)](currentMode,_0x49bf3a['ZIWtb']))return;const _0x1c8b20=questionsData[currentQuestionIndex];document[_0x7fd54f(0x2bd)](_0x49bf3a['UAPyC'])[_0x7fd54f(0x2a2)]=_0x1c8b20['solution']||_0x49bf3a[_0x7fd54f(0x3d7)];const _0x51e332=document[_0x7fd54f(0x2bd)](_0x49bf3a[_0x7fd54f(0x1fa)]),_0x47c8a7=document[_0x7fd54f(0x2bd)]('explanationVideoPlayer'),_0x4bdf26=_0x1c8b20[_0x7fd54f(0x34d)];if(_0x4bdf26){if(_0x49bf3a[_0x7fd54f(0x397)](_0x7fd54f(0x3c1),_0x49bf3a[_0x7fd54f(0x352)]))_0x49bf3a['NYOxd'](_0x120b10,_0x49bf3a[_0x7fd54f(0x37f)])&&(_0x558403['location'][_0x7fd54f(0x3c3)][_0x7fd54f(0x361)](_0x7fd54f(0x43d))&&_0x5d736b['removeItem'](_0x49bf3a[_0x7fd54f(0x423)]),_0x49bf3a['FCqAH'](_0x5c4114),_0x135cb0[_0x7fd54f(0x1f6)]());else{_0x51e332[_0x7fd54f(0x1d5)]['remove'](_0x49bf3a[_0x7fd54f(0x264)]);if(_0x4bdf26[_0x7fd54f(0x1fb)](_0x49bf3a[_0x7fd54f(0x257)]))_0x49bf3a[_0x7fd54f(0x259)](setupVideo,_0x47c8a7,_0x4bdf26);else _0x47c8a7[_0x7fd54f(0x21f)]=_0x4bdf26;}}else{if(_0x49bf3a[_0x7fd54f(0x277)](_0x49bf3a[_0x7fd54f(0x372)],_0x49bf3a[_0x7fd54f(0x372)]))_0x51e332[_0x7fd54f(0x1d5)][_0x7fd54f(0x2c9)](_0x7fd54f(0x29b));else{const _0x2d3518={'LUSHW':function(_0x305e59,_0x2ec029){const _0x57f3d7=_0x7fd54f;return _0x49bf3a[_0x57f3d7(0x465)](_0x305e59,_0x2ec029);},'xQnoL':function(_0x1c8e4f,_0x342f17){const _0x3eb555=_0x7fd54f;return _0x49bf3a[_0x3eb555(0x25a)](_0x1c8e4f,_0x342f17);},'nwyuA':_0x49bf3a[_0x7fd54f(0x29d)],'eOKCd':_0x7fd54f(0x327),'jtkEV':_0x49bf3a['WhIcy']};_0x4e4e4c['choices'][_0x7fd54f(0x248)]((_0xb850f4,_0x51616d)=>{const _0x448bee=_0x7fd54f,_0xfcfcb9=_0x3090f3[_0x448bee(0x29e)](_0x2d3518['LUSHW'](0x41,_0x51616d)),_0x5b706b=_0x2d3518[_0x448bee(0x2cb)](_0x1d019d,_0x51616d),_0x585901=_0x2b3dac['createElement'](_0x2d3518[_0x448bee(0x282)]);_0x585901[_0x448bee(0x2a2)]=_0x448bee(0x2af)+(_0x5b706b?_0x2d3518[_0x448bee(0x2e5)]:'')+_0x448bee(0x378)+_0x51616d+_0x448bee(0x38f)+_0xfcfcb9+_0x448bee(0x393)+(_0xb850f4[_0x448bee(0x28d)]||_0x2d3518[_0x448bee(0x424)]+_0x2d3518[_0x448bee(0x32f)](_0x51616d,0x1))+_0x448bee(0x28c),_0x5c8d80[_0x448bee(0x255)](_0x585901);}),_0x22a291[_0x7fd54f(0x1cb)](_0x49bf3a[_0x7fd54f(0x3bc)],function(_0x823ca9){const _0x5ca957=_0x7fd54f,_0x53de5c=_0x823ca9[_0x5ca957(0x35d)][_0x5ca957(0x245)](_0x49bf3a[_0x5ca957(0x216)]);if(_0x53de5c){const _0x28fd1c=_0x49bf3a[_0x5ca957(0x312)](_0xfe40b1,_0x53de5c[_0x5ca957(0x385)](_0x49bf3a[_0x5ca957(0x353)]));_0x49bf3a[_0x5ca957(0x441)](_0x310bbc,_0x28fd1c);}});}}const _0x210053=document[_0x7fd54f(0x2bd)](_0x49bf3a[_0x7fd54f(0x426)]);_0x210053[_0x7fd54f(0x2a2)]='';_0x1c8b20[_0x7fd54f(0x27d)]&&(_0x210053[_0x7fd54f(0x2a2)]+=_0x7fd54f(0x21c)+_0x1c8b20[_0x7fd54f(0x27d)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>');if(_0x1c8b20[_0x7fd54f(0x1c2)]){if(_0x49bf3a[_0x7fd54f(0x277)](_0x49bf3a[_0x7fd54f(0x32c)],'kFLdD'))_0x210053[_0x7fd54f(0x2a2)]+=_0x7fd54f(0x31a)+_0x1c8b20[_0x7fd54f(0x1c2)]+_0x7fd54f(0x219);else{const _0x2c9e9d=_0x3ac65c[_0x7fd54f(0x2bd)](_0x49bf3a[_0x7fd54f(0x2c6)]),_0x1511db=_0xe70bf0[_0x7fd54f(0x2bd)](_0x49bf3a[_0x7fd54f(0x35f)]),_0x4686dd=_0x4dffd9[_0x3b9802][_0x7fd54f(0x44b)];_0x2c9e9d[_0x7fd54f(0x215)]=_0x4686dd?_0x7fd54f(0x1fc):_0x49bf3a[_0x7fd54f(0x280)],_0x1511db[_0x7fd54f(0x371)]=_0x4686dd?_0x49bf3a['RfCVr']:_0x49bf3a[_0x7fd54f(0x337)];}}const _0x40bc08=document[_0x7fd54f(0x2bd)](_0x49bf3a[_0x7fd54f(0x444)]);_0x40bc08[_0x7fd54f(0x2a2)]='',_0x1c8b20[_0x7fd54f(0x3bb)]&&_0x1c8b20[_0x7fd54f(0x3bb)][_0x7fd54f(0x248)](_0x545712=>{const _0x3b4c86=_0x7fd54f,_0x261126={'NfFyU':_0x49bf3a[_0x3b4c86(0x21a)],'bFsDn':_0x49bf3a[_0x3b4c86(0x2b4)]};if(_0x49bf3a[_0x3b4c86(0x25a)](_0x49bf3a[_0x3b4c86(0x377)],_0x49bf3a[_0x3b4c86(0x1e9)])){if(_0x1229f7[_0x3b4c86(0x2c0)]!==null)_0x597800=_0x261126['NfFyU'];else _0x4cba97=_0x261126[_0x3b4c86(0x33e)];}else{if(_0x545712)_0x40bc08[_0x3b4c86(0x2a2)]+='<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x545712+_0x3b4c86(0x20f);}}),document[_0x7fd54f(0x2bd)](_0x49bf3a[_0x7fd54f(0x26c)])[_0x7fd54f(0x1d5)][_0x7fd54f(0x318)](_0x7fd54f(0x29b));}function submitQuiz(){const _0x2f801a=_0x2bb813,_0x15dfd9={'qTbbx':function(_0x42f2bb,_0x36f1c6){return _0x42f2bb===_0x36f1c6;},'qqjme':function(_0x259e07,_0x3c65e6){return _0x259e07!==_0x3c65e6;},'Qmbvv':_0x2f801a(0x295),'QiJfZ':_0x2f801a(0x2cc),'kYcwt':'correct','VpWfR':function(_0x23a630,_0x571915){return _0x23a630(_0x571915);},'CqDgE':function(_0x418131,_0x41213f){return _0x418131(_0x41213f);},'ufZxH':function(_0x2b1876,_0x355feb){return _0x2b1876-_0x355feb;},'vKNjP':'quizPerformanceData','cialv':function(_0x1ecd39,_0x474fa2){return _0x1ecd39+_0x474fa2;},'KaLyI':function(_0x2adf78){return _0x2adf78();}};if(timer)_0x15dfd9['VpWfR'](clearInterval,timer);if(!_0x15dfd9[_0x2f801a(0x3b8)](confirm,'Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?'))return;isQuizCompleted=!![];let _0xf22831=0x0,_0x50a5b6=0x0;const _0x360eda=_0x15dfd9[_0x2f801a(0x3ca)](Date[_0x2f801a(0x34f)](),quizStartTime);questionsData['forEach']((_0xa79174,_0x5725e5)=>{const _0x41a012=_0x2f801a,_0x17b0dd={'ZyNvt':function(_0x454c59,_0x542c4a){const _0x1fa780=_0x1e9d;return _0x15dfd9[_0x1fa780(0x1d2)](_0x454c59,_0x542c4a);}},_0xe7b5b9=questionStates[_0x5725e5];_0x15dfd9[_0x41a012(0x2a1)](_0xe7b5b9[_0x41a012(0x2c0)],null)&&(_0x15dfd9['Qmbvv']===_0x15dfd9['QiJfZ']?_0x382306['classList'][_0x41a012(0x440)](_0x41a012(0x327),_0x17b0dd[_0x41a012(0x2bb)](_0x3bd73a,_0x1975a3)):_0xa79174[_0x41a012(0x2e7)][_0xe7b5b9['selectedAnswer']]['id']===_0xa79174[_0x41a012(0x2d3)]?(_0xf22831++,_0xe7b5b9['status']=_0x15dfd9[_0x41a012(0x32b)]):(_0x50a5b6++,_0xe7b5b9[_0x41a012(0x458)]=_0x41a012(0x316)));});const _0x4836f2=JSON[_0x2f801a(0x33a)](localStorage[_0x2f801a(0x416)](_0x15dfd9[_0x2f801a(0x21d)]))||[];_0x4836f2[_0x2f801a(0x1ba)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date['now'](),'totalTime':_0x360eda,'stats':{'correct':_0xf22831,'incorrect':_0x50a5b6,'notAttempted':questionsData[_0x2f801a(0x3f7)]-_0x15dfd9[_0x2f801a(0x2e0)](_0xf22831,_0x50a5b6)}}),localStorage[_0x2f801a(0x299)](_0x15dfd9[_0x2f801a(0x21d)],JSON[_0x2f801a(0x3ba)](_0x4836f2)),stats[_0x2f801a(0x317)]=_0xf22831,stats[_0x2f801a(0x3de)]=_0x50a5b6,_0x15dfd9[_0x2f801a(0x356)](markQuizAsCompleted),showPerformanceAnalysis(_0xf22831,_0x50a5b6,_0x15dfd9['ufZxH'](questionsData[_0x2f801a(0x3f7)],_0x15dfd9['cialv'](_0xf22831,_0x50a5b6)),_0x360eda);}function showPerformanceAnalysis(_0x113618,_0x54ec47,_0x2d0ec1,_0x11c01a){const _0x1f9b6b=_0x2bb813,_0x31651b={'kzGOs':_0x1f9b6b(0x2df),'gQZbr':function(_0x4a5ab4,_0x3860cd){return _0x4a5ab4>_0x3860cd;},'sdBOE':function(_0x462c8c,_0xe9e43c){return _0x462c8c+_0xe9e43c;},'XcFxP':function(_0x4f8559,_0x79ca61){return _0x4f8559/_0x79ca61;},'rDXzr':function(_0x58e5ba,_0x446908){return _0x58e5ba*_0x446908;},'TQHFK':_0x1f9b6b(0x2d7),'CsImF':function(_0x1917c5,_0x1fc5b7){return _0x1917c5/_0x1fc5b7;},'Vapyv':_0x1f9b6b(0x298),'WlKdI':_0x1f9b6b(0x2ac),'PhqIT':_0x1f9b6b(0x360),'jlUEV':'incorrectResult','xYbYI':_0x1f9b6b(0x44e),'oCsvc':function(_0x4bb256,_0x11e809){return _0x4bb256/_0x11e809;},'qXMux':function(_0x1fe7e6,_0x32e5f6){return _0x1fe7e6%_0x32e5f6;},'EGltn':_0x1f9b6b(0x39c),'IvpDn':_0x1f9b6b(0x285),'xPfOW':_0x1f9b6b(0x29b)},_0x3a353c=document[_0x1f9b6b(0x2bd)](_0x31651b['kzGOs']),_0x383843=_0x31651b['gQZbr'](_0x31651b[_0x1f9b6b(0x3ac)](_0x113618,_0x54ec47),0x0)?Math[_0x1f9b6b(0x36a)](_0x31651b[_0x1f9b6b(0x345)](_0x113618,_0x31651b[_0x1f9b6b(0x3ac)](_0x113618,_0x54ec47))*0x64):0x0,_0x29502b=_0x31651b['rDXzr'](0x2,Math['PI'])*0x41,_0x219c62=document[_0x1f9b6b(0x2bd)](_0x31651b['TQHFK']);_0x219c62[_0x1f9b6b(0x27b)][_0x1f9b6b(0x349)]=_0x29502b+'\x20'+_0x29502b,_0x219c62[_0x1f9b6b(0x27b)]['strokeDashoffset']=_0x29502b-_0x31651b[_0x1f9b6b(0x32d)](_0x383843,0x64)*_0x29502b,document['getElementById'](_0x31651b[_0x1f9b6b(0x247)])[_0x1f9b6b(0x371)]=_0x383843+'%',document[_0x1f9b6b(0x2bd)](_0x31651b[_0x1f9b6b(0x2b1)])[_0x1f9b6b(0x371)]=questionsData[_0x1f9b6b(0x3f7)],document[_0x1f9b6b(0x2bd)](_0x31651b[_0x1f9b6b(0x42d)])[_0x1f9b6b(0x371)]=_0x113618,document['getElementById'](_0x31651b[_0x1f9b6b(0x1e8)])[_0x1f9b6b(0x371)]=_0x54ec47,document['getElementById'](_0x31651b[_0x1f9b6b(0x238)])[_0x1f9b6b(0x371)]=_0x2d0ec1;const _0x1e6147=Math[_0x1f9b6b(0x29c)](_0x31651b[_0x1f9b6b(0x32d)](_0x11c01a,0xea60)),_0x24d619=Math[_0x1f9b6b(0x29c)](_0x31651b[_0x1f9b6b(0x2da)](_0x31651b[_0x1f9b6b(0x402)](_0x11c01a,0xea60),0x3e8));document[_0x1f9b6b(0x2bd)](_0x31651b[_0x1f9b6b(0x33d)])['textContent']=_0x1e6147+':'+_0x24d619[_0x1f9b6b(0x3bd)]()[_0x1f9b6b(0x1f9)](0x2,'0');const _0x14e97b=_0x31651b[_0x1f9b6b(0x32d)](_0x11c01a,questionsData['length']),_0x1621f6=Math[_0x1f9b6b(0x29c)](_0x14e97b/0xea60),_0x3eaa78=Math[_0x1f9b6b(0x29c)](_0x31651b[_0x1f9b6b(0x402)](_0x14e97b,0xea60)/0x3e8);document[_0x1f9b6b(0x2bd)](_0x31651b[_0x1f9b6b(0x221)])[_0x1f9b6b(0x371)]=_0x1621f6+':'+_0x3eaa78[_0x1f9b6b(0x3bd)]()['padStart'](0x2,'0'),_0x3a353c[_0x1f9b6b(0x1d5)][_0x1f9b6b(0x318)](_0x31651b['xPfOW']);}function closePerformanceModal(){const _0x43acf0=_0x2bb813,_0x4fe210={'BEohG':'performanceModal','hHuJc':'hidden'};document[_0x43acf0(0x2bd)](_0x4fe210['BEohG'])[_0x43acf0(0x1d5)][_0x43acf0(0x2c9)](_0x4fe210[_0x43acf0(0x45b)]);}function reviewQuestions(){const _0x49f6bc=_0x2bb813,_0x365486={'JbVVg':_0x49f6bc(0x420),'LHoGu':function(_0x27e285){return _0x27e285();},'Lucaa':function(_0x2ebcd4,_0x4fc48f){return _0x2ebcd4===_0x4fc48f;},'JfSua':_0x49f6bc(0x291),'JgFAl':_0x49f6bc(0x446),'xHbvH':_0x49f6bc(0x2c5),'drarK':function(_0x1013f1,_0x3d1b6d){return _0x1013f1+_0x3d1b6d;},'RgGvq':_0x49f6bc(0x3d9),'sUzzw':'NsuQd','VJUIS':'not-attempted','yVPQW':function(_0x241784,_0xbc20d4){return _0x241784!==_0xbc20d4;},'TDQTF':'hywyH','lNMqH':'YVitq','fJHxr':_0x49f6bc(0x34a),'LwAbA':_0x49f6bc(0x316),'TVEML':_0x49f6bc(0x28f),'jiqlD':_0x49f6bc(0x313),'kCuWe':function(_0x1b93d9,_0x1e1011){return _0x1b93d9+_0x1e1011;},'GVkzH':_0x49f6bc(0x1b8),'NPdfb':_0x49f6bc(0x43f),'xpesJ':_0x49f6bc(0x204),'ORTFY':_0x49f6bc(0x1f0),'ekiJW':_0x49f6bc(0x29b)};document['getElementById'](_0x365486[_0x49f6bc(0x297)])[_0x49f6bc(0x1d5)][_0x49f6bc(0x318)](_0x365486[_0x49f6bc(0x1bb)]);const _0x34cbea=document['getElementById'](_0x49f6bc(0x46a));_0x34cbea['innerHTML']='',questionsData[_0x49f6bc(0x248)]((_0x7f5db5,_0x3b5121)=>{const _0x451100=_0x49f6bc;if(_0x365486[_0x451100(0x38d)](_0x365486[_0x451100(0x23e)],_0x365486['sUzzw'])){const _0xc367b0=!_0x2f566e[_0x451662]['bookmarked'];_0x4de0a0[_0x3bcc3a][_0x451100(0x1db)]=_0xc367b0;let _0xa1d979=_0x489774['parse'](_0x66f67f[_0x451100(0x416)](_0x451100(0x420)))||[];if(_0xc367b0){const _0x259162={'quizName':_0x19dc25,'quizFile':_0x2ccd80[_0x451100(0x307)][_0x451100(0x3c3)][_0x451100(0x289)]('/')[_0x451100(0x456)](),'questionIndex':_0x10dd28,'question':_0x31cfaa[_0x55acbe],'hierarchy':_0x3a951c,'timestamp':_0x3e1258[_0x451100(0x34f)]()};_0xa1d979[_0x451100(0x1ba)](_0x259162);}else _0xa1d979=_0xa1d979[_0x451100(0x3e5)](_0x4f88c0=>!(_0x4f88c0[_0x451100(0x20a)]['includes'](_0x30e1a3[_0x451100(0x30d)]()['replace'](/ /g,'-'))&&_0x4f88c0[_0x451100(0x351)]===_0x598c4a));_0x572e09[_0x451100(0x299)](_0x365486['JbVVg'],_0x18e779['stringify'](_0xa1d979)),_0x365486[_0x451100(0x382)](_0x146bdf),_0x2b02e7();}else{const _0x56caaf=questionStates[_0x3b5121],_0x9d2083=_0x7f5db5[_0x451100(0x2d3)];let _0x3c94a9=_0x365486['VJUIS'],_0x442858=_0x451100(0x254);if(_0x365486[_0x451100(0x443)](_0x56caaf[_0x451100(0x2c0)],null)){if(_0x365486[_0x451100(0x443)](_0x365486['TDQTF'],_0x365486[_0x451100(0x28e)]))_0x365486[_0x451100(0x382)](_0xb9dad0);else{const _0x30e9ba=_0x7f5db5[_0x451100(0x2e7)][_0x56caaf[_0x451100(0x2c0)]];_0x365486[_0x451100(0x38d)](_0x30e9ba['id'],_0x9d2083)?_0x365486[_0x451100(0x38d)]('mgnZV',_0x365486[_0x451100(0x3ef)])?(_0x4af6df++,_0x1eb1f5['status']=_0x451100(0x316)):(_0x3c94a9=_0x365486[_0x451100(0x3b1)],_0x442858='Correct'):(_0x3c94a9=_0x365486[_0x451100(0x293)],_0x442858=_0x365486[_0x451100(0x1f3)]);}}const _0x4d2787=document[_0x451100(0x2e1)](_0x365486[_0x451100(0x42b)]);_0x4d2787['className']=_0x451100(0x31d)+_0x3c94a9;let _0x9b582c=(_0x7f5db5[_0x451100(0x2e7)]||[])[_0x451100(0x28b)]((_0x1a8719,_0x14b0d6)=>{const _0x20ce3a=_0x451100,_0x2adf1a=_0x365486[_0x20ce3a(0x38d)](_0x56caaf[_0x20ce3a(0x2c0)],_0x14b0d6),_0x11b02a=_0x365486[_0x20ce3a(0x38d)](_0x1a8719['id'],_0x9d2083);let _0x575f18=_0x365486[_0x20ce3a(0x2ae)];if(_0x11b02a)_0x575f18=_0x365486['JgFAl'];else{if(_0x2adf1a)_0x575f18=_0x365486[_0x20ce3a(0x3c2)];}return'<div\x20class=\x22p-3\x20rounded-lg\x20border\x20'+_0x575f18+_0x20ce3a(0x1de)+String[_0x20ce3a(0x29e)](_0x365486[_0x20ce3a(0x3e9)](0x41,_0x14b0d6))+_0x20ce3a(0x2dd)+_0x1a8719[_0x20ce3a(0x28d)]+_0x20ce3a(0x350);})[_0x451100(0x394)]('');const _0x1a7a6b=_0x7f5db5[_0x451100(0x34d)]?_0x451100(0x241)+_0x3b5121+'\x22\x20data-src=\x22'+_0x7f5db5[_0x451100(0x34d)]+'\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>':'';let _0x4f8951='';if(_0x7f5db5['explanation_audio_eng'])_0x4f8951+=_0x451100(0x25f)+_0x7f5db5['explanation_audio_eng']+_0x451100(0x219);if(_0x7f5db5[_0x451100(0x1c2)])_0x4f8951+=_0x451100(0x379)+_0x7f5db5[_0x451100(0x1c2)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';let _0x51b000=(_0x7f5db5['explanation_images']||[])[_0x451100(0x28b)](_0x2b0c21=>_0x2b0c21?_0x451100(0x2e4)+_0x2b0c21+_0x451100(0x20f):'')[_0x451100(0x394)]('');_0x4d2787['innerHTML']=_0x451100(0x39a)+_0x365486[_0x451100(0x253)](_0x3b5121,0x1)+_0x451100(0x229)+(_0x3c94a9===_0x365486[_0x451100(0x3b1)]?_0x365486[_0x451100(0x310)]:_0x365486['Lucaa'](_0x3c94a9,_0x365486[_0x451100(0x293)])?_0x365486[_0x451100(0x25e)]:_0x365486[_0x451100(0x284)])+_0x451100(0x464)+_0x442858+_0x451100(0x3e4)+_0x7f5db5[_0x451100(0x28d)]+_0x451100(0x272)+_0x9b582c+_0x451100(0x315)+(_0x7f5db5[_0x451100(0x24f)]||_0x451100(0x438))+_0x451100(0x437)+_0x1a7a6b+_0x451100(0x469)+_0x4f8951+_0x451100(0x469)+_0x51b000+_0x451100(0x21e),_0x34cbea[_0x451100(0x255)](_0x4d2787);}}),_0x365486[_0x49f6bc(0x382)](initializeReviewVideos);}function initializeReviewVideos(){const _0x2f3c85=_0x2bb813,_0x396c9={'RbSXy':function(_0x29539b,_0x4c7de8,_0x1ad4cf){return _0x29539b(_0x4c7de8,_0x1ad4cf);},'WEJJv':'video[data-src]'};document[_0x2f3c85(0x3b0)](_0x396c9[_0x2f3c85(0x234)])[_0x2f3c85(0x248)](_0x45e665=>{const _0x1e6792=_0x2f3c85,_0x2c90d1=_0x45e665[_0x1e6792(0x232)][_0x1e6792(0x21f)];if(_0x2c90d1&&_0x2c90d1[_0x1e6792(0x1fb)](_0x1e6792(0x2ab)))_0x396c9['RbSXy'](setupVideo,_0x45e665,_0x2c90d1);else _0x2c90d1&&(_0x45e665['src']=_0x2c90d1);});}function retakeQuiz(){const _0x2f0220=_0x2bb813,_0x561f7d={'LalVC':function(_0x65e1ad,_0x1cbde5){return _0x65e1ad(_0x1cbde5);},'agRXa':_0x2f0220(0x338),'oAghl':'customQuizData','DWWSg':function(_0x264139){return _0x264139();}};_0x561f7d[_0x2f0220(0x36c)](confirm,_0x561f7d[_0x2f0220(0x2ed)])&&(window['location'][_0x2f0220(0x3c3)]['endsWith'](_0x2f0220(0x43d))&&localStorage[_0x2f0220(0x3c4)](_0x561f7d[_0x2f0220(0x1d8)]),_0x561f7d[_0x2f0220(0x20b)](clearProgress),location['reload']());}function loadBookmarkedQuestions(){const _0x1c6da9=_0x2bb813,_0x37e4d1={'LUGHu':function(_0x315ece,_0xd5a593){return _0x315ece===_0xd5a593;},'tpDLb':_0x1c6da9(0x2b9),'dYyhT':_0x1c6da9(0x23d),'eczUp':function(_0x395b28,_0x4e12a2){return _0x395b28<_0x4e12a2;},'kDvgK':_0x1c6da9(0x420)},_0x1395b4=JSON[_0x1c6da9(0x33a)](localStorage['getItem'](_0x37e4d1[_0x1c6da9(0x387)]))||[];_0x1395b4[_0x1c6da9(0x248)](_0x2b2689=>{const _0x5d29b3=_0x1c6da9;_0x37e4d1[_0x5d29b3(0x452)](_0x37e4d1[_0x5d29b3(0x339)],_0x37e4d1[_0x5d29b3(0x2a4)])?_0x1446f3[_0x436d16[_0x5d29b3(0x351)]][_0x5d29b3(0x1db)]=!![]:_0x2b2689[_0x5d29b3(0x20a)]['includes'](quizName['toLowerCase']()[_0x5d29b3(0x39b)](/ /g,'-'))&&(_0x37e4d1[_0x5d29b3(0x3d1)](_0x2b2689[_0x5d29b3(0x351)],questionsData['length'])&&(questionStates[_0x2b2689['questionIndex']][_0x5d29b3(0x1db)]=!![]));});}function toggleBookmark(){const _0x8840cd=_0x2bb813,_0x3b0a73={'GWZbE':function(_0x3247d8){return _0x3247d8();},'VKURp':_0x8840cd(0x420),'jRbIT':_0x8840cd(0x3be),'eWqpJ':function(_0xe5cb19){return _0xe5cb19();}},_0x345aed=!questionStates[currentQuestionIndex][_0x8840cd(0x1db)];questionStates[currentQuestionIndex][_0x8840cd(0x1db)]=_0x345aed;let _0x2ceb8a=JSON[_0x8840cd(0x33a)](localStorage[_0x8840cd(0x416)](_0x3b0a73['VKURp']))||[];if(_0x345aed){if(_0x8840cd(0x3ce)===_0x3b0a73['jRbIT'])_0x3b0a73[_0x8840cd(0x3a4)](_0x493daf);else{const _0x1c5a13={'quizName':quizName,'quizFile':window[_0x8840cd(0x307)][_0x8840cd(0x3c3)]['split']('/')[_0x8840cd(0x456)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x8840cd(0x34f)]()};_0x2ceb8a[_0x8840cd(0x1ba)](_0x1c5a13);}}else _0x2ceb8a=_0x2ceb8a[_0x8840cd(0x3e5)](_0x2adfae=>!(_0x2adfae[_0x8840cd(0x20a)][_0x8840cd(0x1fb)](quizName['toLowerCase']()[_0x8840cd(0x39b)](/ /g,'-'))&&_0x2adfae[_0x8840cd(0x351)]===currentQuestionIndex));localStorage['setItem'](_0x3b0a73['VKURp'],JSON['stringify'](_0x2ceb8a)),_0x3b0a73[_0x8840cd(0x20c)](updateBookmarkButton),updateQuestionNav();}function updateBookmarkButton(){const _0x1ffcc4=_0x2bb813,_0x5b28b9={'WoDzk':_0x1ffcc4(0x2c2),'iCHGH':_0x1ffcc4(0x1ee),'Bxnyq':_0x1ffcc4(0x31b)},_0x3a0d42=document[_0x1ffcc4(0x2bd)](_0x5b28b9['WoDzk']),_0x44f08d=document['getElementById'](_0x1ffcc4(0x421)),_0x53b7d6=questionStates[currentQuestionIndex][_0x1ffcc4(0x1db)];_0x3a0d42[_0x1ffcc4(0x215)]=_0x53b7d6?_0x5b28b9[_0x1ffcc4(0x466)]:_0x5b28b9['Bxnyq'],_0x44f08d[_0x1ffcc4(0x371)]=_0x53b7d6?_0x1ffcc4(0x281):_0x1ffcc4(0x302);}function toggleMarkForReview(){const _0x3b59c9=_0x2bb813,_0x31c5e7={'xQvDq':function(_0x207ffe){return _0x207ffe();}};questionStates[currentQuestionIndex][_0x3b59c9(0x44b)]=!questionStates[currentQuestionIndex][_0x3b59c9(0x44b)],_0x31c5e7[_0x3b59c9(0x448)](updateMarkReviewButton),_0x31c5e7[_0x3b59c9(0x448)](updateQuestionNav);}function updateMarkReviewButton(){const _0x563521=_0x2bb813,_0x34b1b6={'Dnekm':_0x563521(0x3cd),'KerFk':_0x563521(0x1fc),'LcMlf':'glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','ahsXD':'Marked','iQiug':_0x563521(0x2b6)},_0x2023b9=document[_0x563521(0x2bd)](_0x34b1b6[_0x563521(0x2b7)]),_0x2078de=document[_0x563521(0x2bd)](_0x563521(0x37b)),_0x24c898=questionStates[currentQuestionIndex]['markedForReview'];_0x2023b9[_0x563521(0x215)]=_0x24c898?_0x34b1b6[_0x563521(0x27a)]:_0x34b1b6[_0x563521(0x388)],_0x2078de[_0x563521(0x371)]=_0x24c898?_0x34b1b6[_0x563521(0x242)]:_0x34b1b6[_0x563521(0x1c7)];}function previousQuestion(){const _0x42ed19=_0x2bb813,_0x338113={'OURcM':function(_0x575efa,_0x2b70ae){return _0x575efa>_0x2b70ae;},'AZJCI':function(_0x1f162f,_0x43d67e){return _0x1f162f-_0x43d67e;},'yxcLI':function(_0x3bba58){return _0x3bba58();},'YuWnK':function(_0x265a4f){return _0x265a4f();}};_0x338113[_0x42ed19(0x413)](currentQuestionIndex,0x0)&&(questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=_0x338113[_0x42ed19(0x3a6)](Date[_0x42ed19(0x34f)](),questionStartTime)),currentQuestionIndex--,_0x338113[_0x42ed19(0x32a)](displayQuestion),_0x338113[_0x42ed19(0x26b)](saveProgress));}function nextQuestion(){const _0x1c9d3f=_0x2bb813,_0x59e559={'mbTmR':function(_0x201764,_0x766134){return _0x201764>=_0x766134;},'rCAlE':function(_0x6398ac,_0x3eb610){return _0x6398ac<_0x3eb610;},'PpBJi':function(_0x467689,_0x2075cf){return _0x467689-_0x2075cf;},'hNPRS':function(_0x3fec48){return _0x3fec48();},'TIPXY':_0x1c9d3f(0x327),'fShrO':function(_0x185fa5,_0x4c7296){return _0x185fa5===_0x4c7296;},'vNuiy':_0x1c9d3f(0x34a),'FZnFo':_0x1c9d3f(0x316),'WiMgX':function(_0x1c2625,_0x332529){return _0x1c2625<_0x332529;},'FqFvd':function(_0x102605){return _0x102605();},'PnVZk':_0x1c9d3f(0x436),'xhtFi':'test','OrSvL':function(_0x40bd24,_0x575040){return _0x40bd24===_0x575040;},'hArPy':_0x1c9d3f(0x2ba),'wUIoN':function(_0x21490c,_0x2e0a1b){return _0x21490c(_0x2e0a1b);},'fOwlb':function(_0x2140ef,_0x2ba895){return _0x2140ef(_0x2ba895);},'cROxZ':function(_0x3094e1){return _0x3094e1();}};questionStartTime&&(_0x1c9d3f(0x42a)!==_0x1c9d3f(0x42a)?_0x59e559[_0x1c9d3f(0x212)](_0x4881b7,0x0)&&_0x59e559['rCAlE'](_0xf9ddce,_0x4580b7['length'])&&(_0x2419f8&&(_0x36c568[_0x224572]['timeSpent']+=_0x59e559[_0x1c9d3f(0x2c4)](_0x464c88['now'](),_0xdb673f)),_0x51bbd9=_0x67ff26,_0x59e559[_0x1c9d3f(0x3f1)](_0x9b6aed),_0x59e559['hNPRS'](_0x28dbb9)):questionStates[currentQuestionIndex]['timeSpent']+=Date[_0x1c9d3f(0x34f)]()-questionStartTime);if(_0x59e559[_0x1c9d3f(0x36d)](currentQuestionIndex,questionsData[_0x1c9d3f(0x3f7)]-0x1))currentQuestionIndex++,_0x59e559['FqFvd'](displayQuestion),_0x59e559[_0x1c9d3f(0x2d9)](saveProgress);else{if(_0x59e559[_0x1c9d3f(0x364)](_0x59e559[_0x1c9d3f(0x3a0)],_0x59e559[_0x1c9d3f(0x3a0)]))_0x59e559[_0x1c9d3f(0x364)](currentMode,_0x59e559['xhtFi'])||_0x59e559[_0x1c9d3f(0x31c)](currentMode,_0x59e559[_0x1c9d3f(0x208)])?_0x59e559[_0x1c9d3f(0x2cf)](confirm,_0x1c9d3f(0x35b))&&_0x59e559['FqFvd'](submitQuiz):_0x59e559[_0x1c9d3f(0x320)](confirm,_0x1c9d3f(0x1e2))&&(currentQuestionIndex=0x0,_0x59e559[_0x1c9d3f(0x417)](displayQuestion),_0x59e559['FqFvd'](saveProgress));else{_0xcd91cc[_0x1c9d3f(0x1d5)]['remove'](_0x59e559[_0x1c9d3f(0x286)]);if(_0x59e559[_0x1c9d3f(0x364)](_0x3824ae,_0x588e4d))_0xb1a0[_0x1c9d3f(0x1d5)]['add'](_0x59e559[_0x1c9d3f(0x22f)]);else{if(_0x59e559[_0x1c9d3f(0x364)](_0x2b4f57,_0xe082b)&&!_0x1c031b)_0x342c89[_0x1c9d3f(0x1d5)][_0x1c9d3f(0x2c9)](_0x59e559[_0x1c9d3f(0x303)]);}}}}function startTimer(){const _0x37db48=_0x2bb813,_0x47a155={'cLxnw':function(_0x4f2575){return _0x4f2575();},'bJvNb':function(_0x488a0d,_0x1edb85){return _0x488a0d<=_0x1edb85;},'gazQN':function(_0x4db53c,_0x59597a){return _0x4db53c===_0x59597a;},'DkxQe':_0x37db48(0x2ba),'vNszI':function(_0x275d25){return _0x275d25();},'oAOHk':function(_0x19367e){return _0x19367e();},'DvyFs':function(_0x32b0f7){return _0x32b0f7();},'mhTZm':function(_0xe9c55d,_0x10bbf7,_0x3530c3){return _0xe9c55d(_0x10bbf7,_0x3530c3);}};if(timer)clearInterval(timer);timeRemaining=0x78,_0x47a155[_0x37db48(0x266)](updateTimerDisplay),timer=_0x47a155[_0x37db48(0x1fe)](setInterval,()=>{const _0x21a92a=_0x37db48;timeRemaining--,_0x47a155[_0x21a92a(0x429)](updateTimerDisplay),_0x47a155['bJvNb'](timeRemaining,0x0)&&(clearInterval(timer),_0x47a155[_0x21a92a(0x3a7)](currentMode,_0x47a155['DkxQe'])?_0x47a155[_0x21a92a(0x435)](submitQuiz):_0x47a155['oAOHk'](nextQuestion));},0x3e8);}function updateTimerDisplay(){const _0x135e79=_0x2bb813,_0x42c0c1={'eBkTo':function(_0x506cfa,_0x47e084){return _0x506cfa%_0x47e084;},'eCyAx':'timeDisplay','sGFWL':function(_0x3c671b,_0x3717f5){return _0x3c671b+_0x3717f5;}},_0x2c9f2b=Math[_0x135e79(0x29c)](timeRemaining/0x3c),_0x3037d9=_0x42c0c1[_0x135e79(0x2f2)](timeRemaining,0x3c);document[_0x135e79(0x2bd)](_0x42c0c1[_0x135e79(0x422)])['textContent']=_0x42c0c1[_0x135e79(0x3ea)](_0x2c9f2b,':')+_0x3037d9[_0x135e79(0x3bd)]()[_0x135e79(0x1f9)](0x2,'0');}function _0x1e9d(_0x446686,_0x3aeaca){const _0x19721c=_0x5dea();return _0x1e9d=function(_0x4d8348,_0x15ad2e){_0x4d8348=_0x4d8348-0x1b8;let _0x35977f=_0x19721c[_0x4d8348];return _0x35977f;},_0x1e9d(_0x446686,_0x3aeaca);}function toggleSidebar(){const _0x1bd888=_0x2bb813,_0x5e3848={'UOIky':_0x1bd888(0x411),'oQHnH':'open'};document[_0x1bd888(0x2bd)](_0x5e3848['UOIky'])[_0x1bd888(0x1d5)][_0x1bd888(0x440)](_0x5e3848[_0x1bd888(0x3f0)]);}document[_0x2bb813(0x1cb)]('DOMContentLoaded',()=>{const _0x358ee7=_0x2bb813,_0xf6b2d5={'rETjJ':function(_0x363fef){return _0x363fef();},'gWzzh':_0x358ee7(0x451),'PoqAl':function(_0x35417e,_0x2c6804){return _0x35417e<_0x2c6804;},'DqdBZ':_0x358ee7(0x2ab),'jdiVP':function(_0x3a3276,_0x458734){return _0x3a3276===_0x458734;},'SYLzh':_0x358ee7(0x2ce),'UFuJT':_0x358ee7(0x1d0),'TUban':_0x358ee7(0x1e7),'Uqabt':function(_0x5c7cc3){return _0x5c7cc3();},'WrYpo':_0x358ee7(0x28a),'IIRyP':'custom_quiz.html','fZsYA':function(_0x187e63,_0x15e86e){return _0x187e63===_0x15e86e;},'dNLop':function(_0x272c4c,_0x287a30){return _0x272c4c===_0x287a30;},'BWqDk':_0x358ee7(0x3cc)};if(resume)_0xf6b2d5[_0x358ee7(0x3cf)](_0xf6b2d5[_0x358ee7(0x210)],_0xf6b2d5['UFuJT'])?(_0xf6b2d5[_0x358ee7(0x390)](_0x1e0ee2),_0xe866b3[_0x358ee7(0x2bd)](_0xf6b2d5['gWzzh'])[_0x358ee7(0x27b)][_0x358ee7(0x244)]='flex'):loadProgress()?(document[_0x358ee7(0x2bd)](_0xf6b2d5[_0x358ee7(0x39e)])['style'][_0x358ee7(0x244)]=_0xf6b2d5[_0x358ee7(0x41e)],initializeQuiz()):(_0xf6b2d5['Uqabt'](clearProgress),document[_0x358ee7(0x2bd)](_0x358ee7(0x451))['style'][_0x358ee7(0x244)]=_0xf6b2d5[_0x358ee7(0x396)]);else{if(!window[_0x358ee7(0x307)][_0x358ee7(0x3c3)]['endsWith'](_0xf6b2d5['IIRyP']))_0xf6b2d5[_0x358ee7(0x309)]('CaNGT',_0x358ee7(0x235))?(clearProgress(),document['getElementById'](_0xf6b2d5['gWzzh'])[_0x358ee7(0x27b)][_0x358ee7(0x244)]=_0xf6b2d5[_0x358ee7(0x396)]):_0x3cd773['quizFile']['includes'](_0x134a7a[_0x358ee7(0x30d)]()['replace'](/ /g,'-'))&&(_0xf6b2d5['PoqAl'](_0x17c4d1[_0x358ee7(0x351)],_0x3332c0[_0x358ee7(0x3f7)])&&(_0x207e4a[_0x5bebeb['questionIndex']]['bookmarked']=!![]));else{if(_0xf6b2d5[_0x358ee7(0x1eb)](_0xf6b2d5[_0x358ee7(0x231)],_0x358ee7(0x32e))){const _0x39efcb=_0x5d4ef9[_0x358ee7(0x232)][_0x358ee7(0x21f)];if(_0x39efcb&&_0x39efcb[_0x358ee7(0x1fb)](_0xf6b2d5[_0x358ee7(0x1f1)]))_0x404a88(_0x2e1e7c,_0x39efcb);else _0x39efcb&&(_0x229b45[_0x358ee7(0x21f)]=_0x39efcb);}else initializeQuiz();}}}),document[_0x2bb813(0x1cb)](_0x2bb813(0x237),function(_0x4d23dc){const _0x7525c2=_0x2bb813,_0x246ad7={'kDQkH':_0x7525c2(0x327),'caboz':function(_0x571b4f,_0x2a9646){return _0x571b4f===_0x2a9646;},'RymJj':_0x7525c2(0x316),'HdSRg':function(_0x546ce5,_0x6f289c){return _0x546ce5!==_0x6f289c;},'UKABf':_0x7525c2(0x375),'wMttl':_0x7525c2(0x389),'PaVKU':_0x7525c2(0x3a1),'kcLfv':function(_0x44b9e6){return _0x44b9e6();},'Qxahi':_0x7525c2(0x451),'pubzw':_0x7525c2(0x1e7),'XpHSR':_0x7525c2(0x2df),'DBnjw':_0x7525c2(0x29b),'yeqQa':function(_0x2bbaef,_0x3d6959){return _0x2bbaef<=_0x3d6959;},'frNcN':function(_0x2a6490,_0xcf4775){return _0x2a6490-_0xcf4775;},'dOtGq':function(_0x362686,_0x54a63e){return _0x362686(_0x54a63e);},'xwxXp':function(_0x171eaa,_0x453a43){return _0x171eaa<_0x453a43;},'rHBYh':function(_0x173c99,_0x378906){return _0x173c99(_0x378906);},'Vgmto':function(_0x95f63a,_0xfee02d){return _0x95f63a===_0xfee02d;},'jsrzg':'ahRVd','oHEyy':function(_0x2caea9){return _0x2caea9();},'ngRlr':_0x7525c2(0x2ec),'cCysT':function(_0x383ff4,_0x526bfe){return _0x383ff4===_0x526bfe;},'hhneD':function(_0xf3a87c,_0xbc34b1){return _0xf3a87c===_0xbc34b1;},'dmMty':function(_0x2188d9,_0xfb95cc){return _0x2188d9===_0xfb95cc;},'FKpYA':'study','RUfpV':_0x7525c2(0x236),'RFAGD':'test','pCYXs':_0x7525c2(0x2ba),'UaEwy':function(_0x4c8b83,_0x48038e){return _0x4c8b83===_0x48038e;}};if(_0x246ad7[_0x7525c2(0x324)](document[_0x7525c2(0x2bd)](_0x246ad7['Qxahi'])[_0x7525c2(0x27b)]['display'],_0x246ad7[_0x7525c2(0x414)]))return;if(_0x246ad7[_0x7525c2(0x3ae)](document[_0x7525c2(0x2bd)](_0x246ad7[_0x7525c2(0x3f4)])[_0x7525c2(0x1d5)]['contains'](_0x246ad7[_0x7525c2(0x3b6)]),![]))return;if(_0x4d23dc[_0x7525c2(0x290)]>='1'&&_0x246ad7['yeqQa'](_0x4d23dc['key'],'4')){const _0x7a4db=_0x246ad7[_0x7525c2(0x470)](_0x246ad7[_0x7525c2(0x391)](parseInt,_0x4d23dc[_0x7525c2(0x290)]),0x1),_0x48aeee=document[_0x7525c2(0x3b0)](_0x246ad7['wMttl']);if(_0x246ad7[_0x7525c2(0x294)](_0x7a4db,_0x48aeee['length']))_0x246ad7[_0x7525c2(0x3ed)](selectOption,_0x7a4db);}else{if(_0x246ad7[_0x7525c2(0x2dc)](_0x4d23dc[_0x7525c2(0x290)],'ArrowLeft')){if(_0x7525c2(0x35c)===_0x246ad7[_0x7525c2(0x1cd)]){const _0x5ea91e={'NKYQQ':_0x246ad7['kDQkH'],'glmkv':function(_0x10a97d,_0x7f22f9){const _0x1bb3b3=_0x7525c2;return _0x246ad7[_0x1bb3b3(0x3ae)](_0x10a97d,_0x7f22f9);},'IdLcS':function(_0x2edfc9,_0x23e7ac){return _0x2edfc9===_0x23e7ac;},'xdjKD':_0x246ad7['RymJj']};if(_0x246ad7[_0x7525c2(0x324)](_0x39cee9,_0x7525c2(0x249))&&_0x246ad7[_0x7525c2(0x324)](_0x41b3f7,_0x7525c2(0x236)))return;const _0xb3ff7b=_0x3b8b51[_0x7525c2(0x2bd)](_0x246ad7[_0x7525c2(0x24c)]),_0x2cf83d=_0xb3ff7b['querySelectorAll'](_0x246ad7[_0x7525c2(0x1d3)]),_0x1f5416=_0x38c486[_0x39f1b4],_0xfdb943=_0x1f5416['correct_choice_id'];let _0x5e5027=_0x1f5416[_0x7525c2(0x2e7)][_0x7525c2(0x269)](_0x3e06b3=>_0x3e06b3['id']===_0xfdb943);_0xb3ff7b['classList'][_0x7525c2(0x2c9)](_0x246ad7['PaVKU']),_0x2cf83d[_0x7525c2(0x248)]((_0x4d7523,_0x3552a4)=>{const _0x27e9a5=_0x7525c2;_0x4d7523[_0x27e9a5(0x1d5)][_0x27e9a5(0x318)](_0x5ea91e['NKYQQ']);if(_0x5ea91e['glmkv'](_0x3552a4,_0x5e5027))_0x4d7523[_0x27e9a5(0x1d5)][_0x27e9a5(0x2c9)]('correct');else{if(_0x5ea91e[_0x27e9a5(0x442)](_0x3552a4,_0x2a3ca6)&&!_0x1fe4bf)_0x4d7523[_0x27e9a5(0x1d5)][_0x27e9a5(0x2c9)](_0x5ea91e[_0x27e9a5(0x395)]);}}),_0x246ad7[_0x7525c2(0x2fc)](_0x2b0d5b);}else _0x246ad7[_0x7525c2(0x1c6)](previousQuestion);}else{if(_0x246ad7[_0x7525c2(0x3ae)](_0x4d23dc['key'],_0x246ad7[_0x7525c2(0x207)])||_0x246ad7[_0x7525c2(0x33b)](_0x4d23dc['key'],'\x20'))_0x4d23dc['preventDefault'](),_0x246ad7[_0x7525c2(0x2fc)](nextQuestion);else{if(_0x246ad7['hhneD'](_0x4d23dc['key'][_0x7525c2(0x30d)](),'b')&&(_0x246ad7[_0x7525c2(0x3d2)](currentMode,_0x246ad7[_0x7525c2(0x3c9)])||currentMode===_0x246ad7['RUfpV']))_0x246ad7[_0x7525c2(0x1c6)](toggleBookmark);else{if(_0x4d23dc[_0x7525c2(0x290)][_0x7525c2(0x30d)]()==='m'&&(_0x246ad7['hhneD'](currentMode,_0x246ad7[_0x7525c2(0x454)])||_0x246ad7[_0x7525c2(0x263)](currentMode,_0x246ad7[_0x7525c2(0x217)])))toggleMarkForReview();else _0x246ad7['caboz'](_0x4d23dc[_0x7525c2(0x290)][_0x7525c2(0x30d)](),'s')&&(_0x246ad7['UaEwy'](currentMode,'test')||_0x246ad7[_0x7525c2(0x3d2)](currentMode,'timed_exam'))&&_0x246ad7[_0x7525c2(0x2fc)](submitQuiz);}}}}});</script>

</body></html>